WO2005004753A1 - Atrioventricular heart valve and minimally invasive delivery systems thereof - Google Patents

Atrioventricular heart valve and minimally invasive delivery systems thereof Download PDF

Info

Publication number
WO2005004753A1
WO2005004753A1 PCT/US2003/018375 US0318375W WO2005004753A1 WO 2005004753 A1 WO2005004753 A1 WO 2005004753A1 US 0318375 W US0318375 W US 0318375W WO 2005004753 A1 WO2005004753 A1 WO 2005004753A1
Authority
WO
WIPO (PCT)
Prior art keywords
valve
membrane
cusp
atrioventricular valve
stentless
Prior art date
Application number
PCT/US2003/018375
Other languages
French (fr)
Inventor
Rodolfo C Quijano
Than Nguyen
Hosheng Tu
Original Assignee
3F Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3F Therapeutics, Inc. filed Critical 3F Therapeutics, Inc.
Priority to PCT/US2003/018375 priority Critical patent/WO2005004753A1/en
Priority to AU2003237985A priority patent/AU2003237985A1/en
Publication of WO2005004753A1 publication Critical patent/WO2005004753A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415Manufacturing methods

Definitions

  • the invention herein described relates to cardiac atrioventricular valves and minimally invasive delivery systems thereof.
  • the human heart valve opens up in response to the pressure of blood flow on its leaflets.
  • the human heart valve also closes under the pressure exerted on the same leaflets when blood flow retrogrades. This physiological function of the heart valve prevents the backflow of blood in the heart.
  • the leaflets open by separation from one another and close by apposing each other, approximately 38 million times per year. It can be surmised that under stressful conditions or higher heart rates, the number of separations and appositions increases, as well as the force of impact between the leaflets.
  • a natural heart valve can cause a natural heart valve to dysfunction. This may occur due to the decay, degeneration or disruption of the heart valve and/or its components.
  • a prosthetic heart valve is used to repair or replace the natural heart valve. Characteristics of a typical prosthetic heart valve may include hemodynamic performance, thrombogenicity, durability and ease of surgical implantation.
  • the shape of the leaflet and surrounding elements of a valve or a prosthetic valve apparatus is dependent on the function of the heart.
  • numerous publications have taught that the valve shape directs the function of the heart.
  • new paradigms have explained that it is the function of the heart that actually directs and defines the formation of the specific shape or form of the valve.
  • This principle of "Form Follows Function” can now be used to produce new valvular mechanisms that more closely mimic the function ofthe native human heart valve.
  • An atrioventricular valve otherwise known as the mitral valve (in the left side of the heart) or the tricuspid valve (in the right side of the heart), is part of a continuum (referred to herein as the valve apparatus) that extends from the myocardium or muscular wall of the lower chambers, through the papillary muscles, the tendinous rope-like elements known as chordae tendinae, and the leaflets.
  • the valve apparatus There is a tricuspid valve apparatus in the right ventricular chamber, and more importantly the mitral valve apparatus within the left ventricular chamber, the pumping function of which provides the systemic flow of blood through the aorta to keep all tissues of the body supplied with oxygenated blood necessary for cellular function and life.
  • These leaflets form a ring-like structure, known as the annulus, that is part ofthe heart's skeleton.
  • the valve apparatus functions as part of a unit composed of multiple interrelated parts, including the ventricular and atrial walls, the valve leaflets, the fibrous skeleton of the heart at the atrioventricular ring, and the subvalvular apparatus.
  • the subvalvular apparatus includes the papillary muscle within the ventricle, and the chordae tendinae which connect the papillary muscle to the valve leaflets.
  • ventricle and the apparatus work in unison to provide proper pumping to systemic or pulmonary circulation and proper arrest of blood return to the chambers ofthe atria.
  • Aortic and pulmonary valves have been replaced with simple trileaflet chemically treated biological valves obtained from animals, or bileaflet mechanical valves without extreme deficiencies in valvular or cardiac function. This is not the case when mitral or tricuspid valves are replaced and the necessary involvement of chordae tendinae and muscular elements of the chamber wall are not united to function in harmony with the valve leaflets. Those valves used in the aortic position cannot alone replace the mitral valve apparatus without anatomical and functional compromise.
  • tissue valves are constructed by sewing the leaflets of pig aortic valves to a stent to hold the leaflets in proper position as a stented porcine valve. They may also be constructed by removing valve leaflets from the pericardial sac of cows or horses and sewing them to a stent as a stented pericardium valve.
  • the stents may be rigid or slightly flexible and covered with cloth (usually a synthetic material sold under the trademark DacronTM or TeflonTM) and attached to a sewing ring for fixation to the patient's native tissue.
  • the porcine, bovine or equine tissue is chemically treated to alleviate any antigenicity.
  • a stentless valve prosthesis generally comprises a biological valve having a suture ring, anchoring skirts at the commissures ofthe valve, and an outer polyester covering.
  • a stentless valve prosthesis secured or supported to the native valve annulus and leaflets reduces tissue stress as the flexible valve prosthesis adapts and conforms to the native valve, so that durability and resistance to wear and calcification are improved.
  • tissue valves do not cause blood clots to form as readily as do the mechanical valves, and therefore, the tissue valves do not typically require lifelong systemic anticoagulation measures.
  • the presence of the stent and sewing ring prevents the tissue valve from being anatomically accurate in comparison to a normal human heart valve.
  • Porcine and bovine pericardial valves not only require chemical preparation (usually involving fixation with glutaraldehyde), but the leaflets must be sutured to cloth-covered stents in order to hold the leaflets in position for proper opening and closing of the valve.
  • a recent advance has been made in this regard by using "stentless" porcine valves that are sutured or supported directly to the patient's native tissues for aortic valve replacement, but the problem of chemical fixation remains.
  • these stentless artificial valves cannot be used for mitral or tricuspid valve replacement.
  • the major limitation of the "Function Follows Form" concept is that no efforts have been made previously to approximate the form of either the mitral valve or the tricuspid valve.
  • valve Percutaneous Intercostal Penetration
  • annuloplasty contracting the valve annulus
  • quadrangular resection narrowing the valve leaflets
  • commissurotomy cutting the valve commissures to separate the valve leaflets
  • shortening mitral or tricuspid valve chordae tendinae reattachment of severed atrioventricular valve chordae tendinae or papillary muscle tissue
  • decalcification of valve and annulus tissue Alternatively, the valve may be replaced, by excising the valve leaflets of the natural valve, and securing a replacement valve in the valve position, usually by suturing the replacement valve to the natural valve annulus.
  • a conventional procedure for approaching the left atrium is by intravascular catheterization from a femoral vein through the cardiac septal which separates the right atrium and the left atrium.
  • This intravascular procedure is not only dangerous and tedious because of its long, tortuous route, but is also of limited use because of the catheter size suitable for insertion intravascularly.
  • Sterman et al. in U.S. Pat. No. 6,283,127, entire contents of which are incorporated herein by reference, discloses a device system and methods facilitating intervention within the heart or great vessels without the need for a median sternotomy or other form of gross thoracotomy, substantially reducing trauma, risk of complication, recovery time, and pain for the patient.
  • surgical procedures may be performed through percutaneous penetrations within intercostal spaces of the patient's rib cage, without cutting, removing, or significantly displacing any of the patient's ribs or sternum.
  • the device systems and methods are particularly well-adapted for heart valve repair and replacement, facilitating visualization within the patient's thoracic cavity, repair or removal of the patient's natural valve, and, if necessary, attachment of a replacement valve in the natural valve position.
  • an atrioventricular valve that can be retracted or folded inside a delivery system or cannula for delivery through a less-invasive intercostal penetration to the desired place, particularly in a left atrium. Thereafter, the retracted valve is released, expanded, separated from the delivery system, and secured to the desired place with a minimally invasive technique.
  • the same minimally invasive system can also deliver a medical device for drug delivery, energy delivery, and tissue ablation, among other applications.
  • a delivery system for delivering therapeutic means in a patient's heart comprising a heart valve configured to be releasably folded inside a lumen of the delivery system through a percutaneous intercostal penetration of a patient's chest.
  • the therapeutic means may also comprise a medical device that has radiofrequency or cryo-energy ablation capability.
  • One aspect of the present invention is to fabricate a stentless and/or supportless atrioventricular valve and a delivery system thereof that avoids the aforementioned disadvantages, wherein the valve comprises a singular membrane of biocompatible material that has at least two cusps configured to form a substantially tubular shape for use as an atrioventricular valve, and wherein the delivery system comprises a short apparatus for approaching the left atrium through a percutaneous intercostal penetration.
  • One aspect of the present invention is to provide a stentless and/or supportless atrioventricular valve comprising a singular membrane of tissue or plastic material.
  • the valve has a sewing ring and at least two cusps hinged continuously from the inner opening ofthe sewing ring, wherein the cusps are an integral part of a continuum from the singular membrane configured or conformed to form a substantially tubular shape for use as an atrioventricular valve, hi one embodiment, the substantially tubular form ofthe disclosed atrioventricular valve follows the "Function Follows Form" concept.
  • Another aspect of the present invention to fabricate a stentless and/or supportless atrioventricular valve with a singular membrane of tissue biomaterial that is chemically treated to reduce its antigenicity.
  • the singular membrane of biomaterial ofthe present invention is a synthetic plastic.
  • Another aspect ofthe present invention to provide a method of forming a stentless and/or supportless atrioventricular valve intended for attaching to a circumferential valve ring and papillary muscles of a patient comprising a singular membrane of biomaterial with at least two cusps, wherein either cusp has a semicircular tip edge joined by two generally straight side edges and wherein each straight side edge is trimmed and configured at an angle of about less than 20 degrees from a reference imaginary central longitudinal line of that cusp.
  • a preferred aspect of the present invention is to provide a delivery system and methods for minimally invasively delivering a medical device or an atrioventricular valve into the anterior of a patient's heart.
  • the delivery system has a securing mechanism for maintaining the system at a desired place during the operation, wherein the securing mechanism may comprise a plurality of vacuum suction elements associated with an inflatable balloon.
  • the sewing ring of the atrioventricular valve is made from a continuum of the singular membrane or is further reinforced by a sewing ring element to enhance the attachment of the sewing ring onto a heat valve annulus of a patient, hi an alternate embodiment, the sewing ring element is made of a biocompatible material selected from a group consisting of non-biodegradable plastic material, biodegradable plastic material, non-biodegradable biological material, biodegradable biological material, and the like.
  • the cusps further comprise texture element(s) at an edge portion of the cusps configured and adapted to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart.
  • the texture elements may be made of polyester, polytetrafluoroethylene fabric, polyurethane, silicone, or other suitable fabrics.
  • a further aspect ofthe invention is to provide a delivery system for accessing a left atrium of a patient through a cardiac wall, the delivery system comprising a cup balloon located at a distal section of the delivery system, wherein the cup balloon has a balloon rim configured for defining an isolated enclosure bordered by the balloon rim of the cup balloon and the cardiac wall.
  • FIG. 1 is a sewing ring element comprising essentially flat side surfaces to be wrapped within a singular membrane of biomaterial for valve fabrication.
  • FIG. 2 is a singular membrane of biomaterial having a hole at about a central region ofthe membrane adapted for valve fabrication ofthe present invention.
  • FIG. 3 is another embodiment of the present invention comprising a pre-trimmed singular membrane of biomaterial having a hole at about a central region ofthe membrane adapted for valve fabrication.
  • FIG. 4 is a first step ofthe valve fabrication by laying a sewing ring element on top ofthe singular membrane of biomaterial.
  • FIG. 5 is a next step of the valve fabrication by wrapping a singular membrane around the sewing ring element.
  • FIG. 6 is a further step of the valve fabrication by inverting a periphery of the singular membrane through an opening ofthe sewing ring element.
  • FIG. 7 is another step of the valve fabrication by securing the singular membrane onto the sewing ring element.
  • FIG. 8 is one further step ofthe valve fabrication by aligning the potential wrinkles or folds adj acent the remote ends portion of the cusps.
  • FIG. 9 is still another step of the valve fabrication by trimming the cusps at a desired angle with reference to an imaginary central straight line of the cusp, wherein the valve is shown at an open position.
  • FIG. 10 is a cross-sectional view of section I - I of FIG. 8, illustrating the distal portion of a cusp comprising texture elements at edge portions of the cusps configured to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart.
  • FIG. 11 is the atrioventricular valve shown at a close position.
  • FIG. 12A is a perspective view of an atrioventricular valve following the blood flow direction.
  • FIG. 12B is a perspective view of an atrioventricular valve against the blood flow direction.
  • FIG. 13 is a delivery system of the present invention for minimally mvasively deploying a medical device to the interior of a body.
  • FIG. 14 is a cross-section view of the distal portion of a delivery system according to the principles ofthe present invention.
  • FIG. 15 is a front cross-sectional view of section II - II of FIG. 14, illustrating a cup balloon element with suction capability.
  • FIG. 16 is a preferred embodiment of the atrioventricular valve that is constrained with a minimal profile during a minimally invasive deployment stage.
  • FIG. 17 is an illustrative view of a medical device being delivered to an interior of a body via a minimally invasive manner.
  • FIGS. 1 to 17 what is shown is an embodiment of a stentless and/or supportless atrioventricular valve and a delivery system thereof comprising a singular membrane of tissue or plastic biomaterial.
  • Most conventional heart valves are manufactured as stented valves.
  • stentless heart valves with more flexible annular rings are available; however, those valves are still typically supported by sutures or clothes on the valve and/or between the cusps and the valve base.
  • a commercially available pericardium valve made by suturing leaflets together to form a valve is not a "supportless valve" according to the present invention.
  • the supportless atrioventricular valve is comprised of an anterior cusp and a posterior cusp, each cusp having two generally straight side edges that are joined at a semicircular tip edge, wherein each ofthe straight side edges is trimmed and configured at an angle of about 20 degrees or less, preferably between a range of 15 to 20 degrees, from a reference central longitudinal line ofthe cusp.
  • the supportless atrioventricular valve has no additional support, such as a conventional stenting element made of metal or plastic material.
  • the supportless atrioventricular valve is quite feasible for delivery to an implant site by a minimally invasive manner.
  • FIG. 1 shows a sewing ring element comprising essentially flat or straight side surfaces to be wrapped within a singular membrane of biomaterial for valve fabrication of the present invention.
  • a sewing ring element 10 having a general configuration of circular, oval shape, D-shape, or other convenient shape may be made of rigid, semi-rigid or flexible biomaterial from synthetic polymer or biological tissue.
  • the sewing ring element 10 in FIG. 1 shows a sewing ring element comprising essentially flat or straight side surfaces to be wrapped within a singular membrane of biomaterial for valve fabrication of the present invention.
  • a sewing ring element 10 having a general configuration of circular, oval shape, D-shape, or other convenient shape may be made of rigid, semi-rigid or flexible biomaterial from synthetic polymer or biological tissue.
  • first top surface 12 bordered by a first inner edge (that is, the inner perimeter) 14 defining the ring opening 11 and a first outer edge 13 (that is, the outer perimeter), a second bottom surface 15 opposite of the first surface 12, wherein the first surface 12 and the second surface 15 are connected by a supporting member of the sewing ring element 10.
  • the second surface 15 is bordered by a second inner edge (that is, perimeter) 16 defining the bottom ring opening 9 and a second outer edge or perimeter 17.
  • the ring opening 11 at the first top surface 12 is identical in shape and size to the bottom ring opening 9.
  • the ring 10 is conformed suitable for suturing or securing onto another material, such as a-singular flexible membrane 20 of the present invention, h a particular embodiment, the configuration or shape ofthe first inner edge 12 may not necessarily match that of the second inner edge 16 while the configuration or shape of the first outer edge 13 may not necessarily match that of the second outer edge 17.
  • the sewing ring opening of the present invention may be "D" shaped and matched by a correspondingly larger D-shaped external profile suitable for placing the atrioventricular valve in a patient heart.
  • a circular, oval shaped or D-shaped ring opening that is flexible for replacing an atrioventricular valve is well known to a cardiac surgeon or skilled artisan.
  • the sewing ring element 10 further comprises an inner perimeter 14 including at least a straight side portion 19 thereof and an outer perimeter 13 having a straight side portion 18.
  • the side portions 18, 19 may also be a non-straight configuration.
  • the cross-section configuration of a sewing ring element may be square, circular, oval, D-shaped, trapezoidal, or other irregular shape.
  • the sewing ring element may be made of a biocompatible material selected from a group consisting of non-biodegradable plastic material, biodegradable plastic material, non-biodegradable biological material, or biodegradable biological material.
  • the sewing ring element may be textured, porous, or constructed of fabric components suitable for valve fabrication.
  • the sewing ring element of the present invention may be a virtual element or a temporary template.
  • the "virtual element” is herein intended to mean an imaginary non-existing element that aids in better describing and assisting the valve fabrication process.
  • the sewing ring element as a temporary template aid is intended to simplify the valve fabrication process, followed by disengaging the template from the finished valve.
  • One example ofthe temporary template is made of a liquid soluble substance that is disengaged from the valve by dissolution or biodegradation.
  • FIG. 2 shows a singular membrane of biomaterial having a hole 26 with its border or perimeter 27 at about a central region of the membrane and a periphery region 35 (shown in FIG. 5) adapted for valve fabrication.
  • the singular flexible membrane 20 has a first membrane surface 28 and an opposite second membrane surface 29.
  • the surface property/morphology of the surface 28 may be similar or different to that of the opposite membrane 29.
  • the membrane surfaces 28, 29 are relatively smooth for intended valve fabrication purposes.
  • the membrane 20 is shaped like a typical rectangular singular sheet that is bordered by four edges 22, 23, 24, and 25 that are part of the periphery 35.
  • the membrane may shape circularly, irregularly without recognizable edges, or in a special design configuration.
  • the membrane 20 may be selected from biological tissue, a synthetic polymer or a synthetic protein matrix.
  • the membrane of biological tissue may be chemically treated to reduce its antigenicity.
  • the chemicals for treating biological tissue may include glutaraldehyde, formaldehyde, dialdehyde starch, polyepoxy compounds, or the like that are well known to one who is skilled in the art of chemical treatment.
  • the membrane of tissue may be pericardium tissue selected from a group consisting of equine, bovine, porcine, ovine, human, or other animals.
  • the thickness of tissue membrane is preferred to be in the range of less than 0J mm up to about a few millimeters.
  • the singular membrane 20 made of synthetic polymer may be selected from a group consisting of polyurethane, silicone, expanded polytetrafluoroethylene, fluoro-polymer, polyester, polyethylene, polypropylene or co-polymer thereof.
  • the singular membrane of the present invention has adequate strength or mechanical properties suitable as a heart valve construct.
  • the singular flexible membrane may be pre-trimmed and shaped for a valve fabrication.
  • FIG. 3 shows another embodiment of the present invention comprising a precut (that is, pre-trimmed) singular membrane 2 of biomaterial having a hole 3 at about a central region of the membrane adapted for valve fabrication.
  • the membrane 2 comprises a first major cusp member 4, a second major cusp member 5, a third minor cusp member 6, and a fourth minor cusp member 7. All cusp members are so pre-trimmed that the final fabricated configuration is suitable as a stentless and/or supportless atrioventricular valve apparatus.
  • the first major cusp member 4 has a first side edge 4A, an opposite second side edge 4B, and a first end edge 4C, and a second end edge 4D. Further, the first major cusp member 4 has a first trimmed edge 4E and a second trimmed edge 4F. Similarly as shown in FIG.
  • the second major cusp member 5 has a first side edge 5 A, an opposite second side edge 5B, and a first end edge 5C, and a second end edge 5D. Further, the second major cusp member 5 has a first trimmed edge 5E and a second trimmed edge 5F. Not all edges ofthe major cusp members 4, 5, or the minor cusp members 6, 7 are straight. The edges may be essentially straight or in other suitable curvature suitable for making the intended valve of the present invention.
  • a first group of the trimmed edges 4E, 5E ofthe present invention is trimmed and configured at an angle ( ⁇ ) of about less than 20 degrees from a reference central longitudinal line and adapted to be a constituent of the posterior cusp 51 (as shown in FIG. 9).
  • the second group ofthe trimmed edges 4F, 5F ofthe present invention is trimmed and configured at an angle ( ⁇ ) of about less than 20 degrees from a reference central longitudinal line and adapted to be a constituent of the anterior cusp 52 (as shown in FIG. 9).
  • the angle ⁇ or ⁇ may preferably be in the range of about 15 to 20 degrees.
  • the third minor cusp member 6 has two side edges 6 A, 6B and an end edge whereas the fourth minor cusp member 7 has two side edges 7A, 7B and an end edge.
  • any edge may be essentially straight or in other suitable curvature suitable for making the intended valve ofthe present invention.
  • FIG. 4 shows a first step of the valve fabrication by laying a sewing ring element 10 on top of the singular membrane 20 of biomaterial so as to substantially match the second ring opening 9 against the membrane opening 26. In an alternate fabrication process using a virtual element, this first step is skipped.
  • a plurality of sutures (either temporary sutures or permanent sutures) 31, 32, 33 or other securing mechanisms to fasten the membrane 20 onto the ring 10 are secured evenly at along the contacting zone between the membrane 20 and the second ring surface 15.
  • FIG. 5 shows a picked- up membrane with the second membrane surface 29 facing exteriorly while the first membrane surface 28 facing interiorly.
  • the periphery region portion 35 where all edges are picked and pulled close to each other is located at about the very top of the combined structure of the ring element 10 and membrane 20.
  • FIG. 5 shows a next step of the valve fabrication by wrapping a singular membrane around the sewing ring element 10.
  • FIG. 6 shows a further step of the valve fabrication by inverting the periphery 35 of the singular membrane through an opening 11 of the sewing ring element 10 so as to form a complete wrapping around the ring element 10.
  • the singular membrane 20 hereby wraps over the first surface 12 ofthe ring element 10 and to continue wrapping around the first inner edge 14 and the second inner edge 16 of the sewing ring element 10.
  • FIG. 6 shows a fully wrapped membrane with the first membrane surface 28 facing exteriorly while the second membrane surface 29 facing interiorly.
  • the portion ofthe membrane-covered sewing ring element is also known as the sewing ring 21 of the atrioventricular valve to be secured to the valvular annulus of a patient.
  • FIG. 7 shows another step of the valve fabrication by securing the singular membrane onto the sewing ring element.
  • the membrane 20 is slightly stretched and re-positioned over the ring 10 so that essentially all the wrinkles 38, 39 are grouped at two opposite ends 36, 37 of the ring element 10. In other words, the majority portion ofthe membrane 20 over the ring element 10 away from the two opposite ends 36, 37 is essentially free of wrinkles.
  • a plurality of sutures 41, 42, 43 or other securing mechanisms are placed substantially equally spaced at along the contacting zone of the membrane and the first ring surface 12.
  • One embodiment of securing the membrane onto the ring element is to suture or stitch the membrane at the second surface 15 to the membrane at the first surface 12 by passing a suture through the ring 10 itself.
  • the ring 10 is to subsequently dissolved after assembly so that a derived sewing ring 21 is made ofthe membrane material alone.
  • FIG. 8 shows one further step of the valve fabrication by aligning the potential wrinkles adjacent the remote ends portion of the cusps
  • FIG. 9 shows still another step of the valve fabrication by trimming the cusps at a desired angle with reference to an imaginary central straight line of the cusp(s). This trimming step may be omitted and substituted by a pre-trimmed singular membrane 2 as shown in FIG. 3.
  • a stentless and/or supportless atrioventricular valve can also be fabricated from a pre-trimmed singular membrane 2.
  • the periphery portion (including cusp members 4, 5, 6, and 7) of the membrane 2 is inverted and passes through the ring opening 11 of the sewing ring element 10.
  • the edge pairs (for example, a pair of edges 4B and 6B; a pair of edges 5B and 6A; a pair of edges 5A and 7A; and a pair of edges 4A and 7B) are secured together to form a substantially tubular shape for use as the atrioventricular valve apparatus.
  • the posterior cusp may comprise the cusp member 7 and its adjacent secured portions of the cusp members 4 and 5.
  • the anterior cusp may comprise the cusp member 6 and its adjacent secured portions ofthe cusp members 4 and 5.
  • the cusp members 4 and 5 are trimmed essentially symmetrical; i.e., the edges 5C, 5D, 5E, and 5F are equivalent counterparts ofthe edges 4C, 4D, 4E, and 4F, respectively.
  • FIG. 9 shows a stentless and/or supportless sewing ring 21 with a trimmed membrane.
  • the periphery portion 35 is trimmed and configured to include a posterior cusp 51 and an anterior cusp 52.
  • the sewing ring 21 of the present invention comprises an opening defined by a perimeter including at least a first and a second straight side portions thereof.
  • An anterior cusp 52 is configured hinged continuously from the first straight side portion while a posterior cusp 51 is configured hinged continuously from the second straight side portion opposite the anterior cusp 52, wherein the anterior cusp and the posterior cusp are an integral part of a continuum from the singular membrane 20 with a common commissure between remote ends 61 of the anterior cusp 52 and the posterior cusp 51.
  • the anterior cusp 52 and the posterior cusp 51 are carried over from the outer surface 18 ofthe sewing ring element 10 and then hinged continuously along the inner surface 19.
  • the membrane-covered sewing ring 21 is formed by an inverted flange portion of the combined cusps 51, 52 located at about the sewing ring place 21 that is configured to shape the sewing ring opening, wherein the flange portion from the cusps 51, 52 is an integral part of a continuum from the singular membrane 20.
  • the atrioventricular valve of the present invention may further comprise a third cusp located between the anterior cusp 52 and the posterior cusp 51, wherein the third cusp hinged continuously from a third straight side portion of the perimeter 14 and wherein the third cusp is an integral part of a continuum from the singular membrane 20 without sutured commissure between any two remote ends of the anterior cusp, the posterior cusp and the third cusp.
  • a cardiac valve with two cusps that is, a bileaflet valve
  • three cusps that is, a trileaflet valve
  • the anterior cusp 52 or the posterior cusp 51 of the atrioventricular valve of the present invention has a generally semicircular or curved edge portion to enable it projecting deeply into the ventricle cavity when the sewing ring 21 is sutured to an atrioventricular junction of a patient heart.
  • the anterior cusp 52 has a semicircular or curved tip edge 65 and two generally straight side edges 63, 64 that are joined at the tip edge 65, wherein each (63 or 64) of the straight side edges is trimmed and configured at an angle ( ⁇ ) of about less than 20 degrees from a reference central longitudinal line 66 ofthe anterior cusp 52 (FIG. 9).
  • FIG. 9 Similarly, in another embodiment as illustrated in FIG.
  • the posterior cusp 51 may have a semicircular or curved tip edge 55 and two generally straight side edges 53, 54 that are joined at the tip edge 55, wherein each ofthe straight side edges 53, 54 is trimmed and configured at an angle ( ⁇ ) of about less than 20 degrees from a reference central longitudinal line 67 ofthe anterior cusp 51 (shown in FIG. 9).
  • the edges at about the cusp joint 61 is so trimmed and configured to exert certain degree of tension for proper valve close and open operations. This tensioned cusp joint 61 is equally true for the case of using a pre-trimmed singular flexible membrane 2.
  • FIG. 10 shows a cross-sectional view of section I - I of FIG. 8, illustrating the distal portion of a cusp comprising texture elements at edge portion(s) of the cusps configured to extend the texture element(s) for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart.
  • a portion ofthe posterior cusp 51 is further shown in FIG. 10 to indicate a plurality of optional openings 73, 74 and an end region 72 of the posterior cusp 51 covered with a texture element 75 made of silicone rubber (SilasticTM), cloth (usually DacronTM), or cloth coated with polytetrafluoroethylene (TeflonTM) or other fabric.
  • a conventional method of securing the texture element onto the cusp may include bonding, stitching, gluing, suturing or the like.
  • the cusp member 7, the right-side portion of the cusp member 4, and the right-side portion of the cusp member 5 are to be joined to fomi the posterior cusp 51 shown in FIG. 10, wherein the cusp members 76, 77, and 78 in FIG. 10 are equivalent counterparts of those referred above.
  • the remote portions 72 ofthe cusp members 76, 77, 78 are joined by the texture element 75.
  • the remaining portions of the edges of the cusp members 76, 77, 78 away from the remote portions 72 may not be secured together and thus may form the openings such as 73, 74.
  • the finished cusp 51 is configured to have lower tension on the cusp member 77 as compared to the adjacent cusp members 76 and 78 and enables the cusps 51, 52 of the present invention to function as a competent atrioventricular heart valve.
  • the anterior cusp 52 and/or the posterior cusp 51 of the present invention may comprise texture elements at edge portions of the cusps configured to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is secured to an atrioventricular junction of a patient's heart.
  • the anatomy of the atrioventricular valves and the subvalvular apparatus of a patient can be found in any medical reference textbook (for example, MITRAL NALNE, edited by H Boudoulas and CF Wooley, published by Futura Publishing, ⁇ Y 2000).
  • the texture elements are formed integral with the cusps 51, 52 and are provided with integral attachment portions at ends 72 remote from the cusps for suturing to the papillary muscles, h one embodiment, the supportless atrioventricular valve apparatus is secured at an atrioventricular junction using a dissolvable or biodegradable material.
  • Angelini and associates (Anatomy ofthe Mitral Valve in MITRAL NALNE, edited by H Boudoulas and CF Wooley, published by Futura Publishing, ⁇ Y 2000), entire contents of which are incorporated herein by reference, teach the mitral valvar complex being attached proximally at the left atrioventricular junction and, distally, through the papillary muscles, to the myocardial wall of the left ventricle. Proper action of the complex depends on normal function and integration of each of the components. Therefore, it is one object of the present invention to provide an atrioventricular valve fabricated from a singular flat membrane of biomaterial adapted to mimic the natural mitral function.
  • the general configuration of either the posterior cusp 51, the anterior cusp 52 or the third cusp in a trileaflet valve apparatus may be slightly concave to exhibit adequate support when secured to the papillary muscles in a ventricle cavity upon deployment.
  • FIG. 9 shows an atrioventricular valve at an open position while FIG. 11 shows the valve at its close position.
  • the ventricle is contracted.
  • the cusp is under quite tension because the remote end of the cusps is still attached to the papillary muscle.
  • the cusps joint section 61 so constructed according to the principles of the present invention enables the valve to close promptly at systole.
  • FIG. 12A shows a perspective view of an atrioventricular valve following the blood flow direction (that is, the valve is open), while FIG. 12B shows a perspective view of an atrioventricular valve against the blood flow direction (that is, the valve is closed).
  • FIG. 13 shows a delivery system of the present invention or delivery means for minimally mvasively deploying a medical device to the interior of a body, particularly through a percutaneous intercostal penetration.
  • the delivery system (also known as "delivery means" for delivering a medical device into a body of a patient) may comprise a delivery apparatus 80 and an inner medical device 107 that is slidably inserted within a lumen 95 of the delivery apparatus 80, wherein the inner medical device may serve as the delivery means for delivering the atrioventricular valve ofthe present invention.
  • the “inner medical device” of the present invention is meant to indicate a device that could be inserted through a lumen ofthe delivery apparatus 80 for advancing into an interior cavity or a patient's heart for therapeutic or diagnostic purposes, including delivering a heart valve, delivering energy to treat tissue, delivering a drug, or the like.
  • a delivery system of the present invention comprises a delivery apparatus 80 having a shaft 89, the shaft 89 having a distal end 81, a distal opening 88A, a proximal end 82, and at least one lumen 95 between the distal end 81 and the proximal end 82.
  • the delivery apparatus 80 also comprises a distal section 83 that is used to releasably secure the distal end 81 at about a cardiac wall during delivering the inner medical device.
  • the delivery apparatus 80 comprises a handle or handpiece 84 that is attached to the proximal end 82 of the shaft 89.
  • the delivery apparatus 80 also comprises a fluid infusion system 85 with a fluid infusion control mechanism 85A for inflating a cup balloon 90 (see FIG. 14) securely attached at the distal section 83 of the apparatus 80.
  • the apparatus 80 comprises a suction mechanism 86 with a suction control mechanism 86A for releasably attaching the cup balloon 90 onto the cardiac wall of a patient.
  • the "cup balloon” of the present invention is a cup, cone, or half-a-ball shape configured for defining an isolated enclosure bordered by the balloon rim of the cup balloon and the cardiac wall.
  • the atrioventricular valve of the present invention is generally characterized by its softness and collapsibility radially for delivery by the inner medical device 107.
  • the delivery apparatus 80 may be made from plastic material, metal or composite material.
  • the delivery apparatus may be made ofthe material selected from the group consisting of polyethylene, polypropylene, polycarbonate, nylon, polytefrafluoroethylene, polyurethane, stainless steel, Nitinol, titanium, polyimide, polyester, and the like.
  • the inner medical device may be made of the material selected from the group consisting of polyethylene, polypropylene, polycarbonate, nylon, polytetrafluoroethylene, polyurethane, stainless steel, Nitinol, titanium, polyimide, polyester, and the like.
  • FIG. 14 shows a cross-section view of the distal section 83 of the delivery apparatus 80 of a delivery system according to the principles of the present invention, h one embodiment, after the apparatus 80 is delivered to adjacent a desired location at the cardiac wall, the rim of the cup balloon 90 in a circular or continuous loop manner is deployed and the suction ports 93 are activated so that the outermost rim 99 in a circular or continuous loop manner of the cup balloon 90 is firmly and suckedly attached to the cardiac wall, defining an attachment rim surface bordered by a balloon inner wall 92B and a balloon outer wall 92A.
  • the inflating fluid is infused to the balloon 90 via a fluid passageway 91 which is a part ofthe overall fluid infusion system 85.
  • the balloon may be made of any typical elastomeric material, such as silicon, latex, polyurethane, mixture or copolymer thereof, or the like.
  • the balloon tends to expand both radially and longitudinally outwardly (shown by an arrow 98).
  • the balloon construction and its use as balloon angioplasty in cardiovascular applications are well known to one who is skilled in the art.
  • the cup balloon of the delivery system is preferably inflated with a saline solution to avoid the possibility of introducing into the patient an air embolism in the event that the balloon ruptured.
  • the balloon should be inflated to a pressure sufficient to form an isolated enclosure to prevent outflow of blood into the surrounding.
  • An intermediate pressure in the order of 10 mmHg to 100 mmHg or more is preferable.
  • the suction or vacuum pressure for the plurality of suction ports is generally in the range of -5 to -100 mmHg.
  • FIG. 15 shows a front cross-sectional view of section II - II of FIG. 14, illustrating the balloon 90 with a plurality of suction ports 93 at its rim 99.
  • Each suction port 93 is connected to the suction mechanism 86 via a suction passageway 94 individually or collectively.
  • the stentless and/or supportless atrioventricular valve 21 of the present invention may be folded inside a lumen 97 of the inner medical device 107 as shown in FIG. 16.
  • FIG. 17 shows an illustrative view of an inner medical device 107 being delivered to the left atrium 106 of a patient, wherein the patient's heart 100 is positioned to show the left atrium 106 and atrium wall 101.
  • the delivery apparatus 80 of a delivery system of the present invention having a cup balloon arrangement 90 at the distal section of the delivery apparatus 80 is deployed through a percutaneous intercostal penetration.
  • the delivery apparatus 80 may be introduced through a cannula or trocar 104 positioned in one of percutaneous intercostal penetrations, the cannula or trocar having a proximal end disposed outside of the patient and a distal end disposed within the chest.
  • a general minimally invasive procedure is well known to ordinary clinicians who are skilled in the art. Examples are U.S. Pat. No. 5,972,030 and No. 5,613,937 to Gan ⁇ son et al, entire contents of which are incorporated herein by reference.
  • a first inner medical device of a sharp scalpel or having a sharp-end is introduced through the opening 88B to create a slit or opening on the wall (either pericardium sac wall, cardiac wall or both).
  • the scalpel is thereafter removed from the delivery system.
  • a second inner medical device of an ablation catheter with at least one electrode may be introduced through the proximal opening 88B.
  • the ablation catheter may be used to ablate one or more pulmonary veins for treating atrial fibrillation.
  • the method for minimally invasively delivering a stentless and/or supportless atrioventricular valve made of a singular membrane of tissue into a patient may further comprise the step of removing at least a portion of a patient's atrioventricular valve by means of a cutting tool introduced through a percutaneous intercostal penetration and through an internal penetration on the cardiac wall.
  • the method may further comprise fastening the atrioventricular valve within the left atrium by means of an instrument introduced through the percutaneous intercostal penetration and through the internal penetration.
  • the percutaneous intercostal penetration is created in a right lateral portion of a patient's chest.
  • a conventional procedure for approaching pulmonary veins in the left atrium is by intravascular catheterization from a femoral vein or artery through the cardiac septal which separates the right atrium and the left atrium.
  • the disadvantages of an intravascular procedure include a long tortuous route (usually a catheter of longer than one meter) that is dangerous and tedious; limited catheter size (usually up to 6 or 7 French catheter size) that can't hold a folded atrioventricular valve; and a leaking cardiac septal that is difficult to re-seal.
  • a third inner medical device having a folded/retracted stentless and/or supportless atrioventricular valve of the present invention at its distal end is introduced through the proximal opening 88B.
  • the valve is deployed out ofthe distal end 96 ofthe inner medical device. Securing a heart valve onto the annulus location using a minimal invasive technique is well known to one who is skilled in the art and constitutes no part of the present invention.
  • the present invention discloses a method of forming a stentless and/or supportless atrioventricular valve intended for attaching to a circumferential valve ring and papillary muscles of a patient as afore-mentioned described.
  • the method may comprise the steps of (a) selecting a singular membrane of biomaterial and an essentially flat sewing ring element, wherein said membrane comprises a hole in about a central region of said membrane and a periphery region, and wherein said sewing ring element comprises an outer diameter and an inner diameter defining an inner straight side portion, an outer straight side portion, a bottom side portion and a top side portion, said hole matching said inner diameter of said sewing ring element; (b) placing said sewing ring element on top of said membrane conformed to align said hole with the inner diameter of said ring element; (c) securing said membrane onto said sewing ring element at a contact region of said membrane to the bottom side portion of the ring element; (d) flapping the membrane around the outer straight side portion and the top side
  • the present invention discloses a method for minimally invasively delivering a stentless and/or supportless atrioventricular valve made of a singular membrane of tissue into a patient, said method comprising folding the valve within a lumen of delivery means for delivering through a cardiac wall into a left atrium of the patient.
  • the method may comprise the steps of (a) advancing a delivery apparatus of the delivery means through a percutaneous intercostal penetration and reaching the cardiac wall, wherein said delivery apparatus comprises a cup balloon at a distal section of the delivery apparatus having a plurality of suction ports at a balloon rim of said cup balloon;
  • a delivery apparatus 80 of the present invention is deployed through an intercostal penetration.
  • the delivery apparatus may be introduced through a cannula or trocar 104 positioned in one of percutaneous intercostal penetrations, the cannula or trocar having a proximal end disposed outside ofthe patient and a distal end disposed within the chest.
  • a method for percutaneously delivering an atrioventricular valve for treating a leaky valve may comprise the steps of: (1) delivering the atrioventricular valve to the anatomical valvular position percutaneously during a delivery phase; (2) deploying the atrioventricular valve during a deployment phase; and (3) placing and securing the atrioventricular valve at about the anatomical valvular annulus.
  • the method may further comprise forming a plurality of percutaneous intercostal penetrations in a patient's chest, each of the percutaneous intercostal penetrations being within an intercostal space between two adjacent ribs, wherein the atrioventricular valve is delivered through one ofthe percutaneous intercostal penetrations.
  • the techniques of the invention also facilitate surgical intervention into other regions of the heart and great vessels.
  • the delivery system and methods described above may be used to form an opening directly into the left ventricle, right atrium, or right ventricle, or into a great vessel such as the aorta, superior vena cava, inferior vena cava, pulmonary artery, or pulmonary vein, for surgical intervention in such cavities.
  • a penetration may be made in the wall of the aorta with a vacuumed enclosure, and the aortic valve may be repaired or replaced with a bioprosthesis, using techniques and delivery systems like those described above for atrioventricular valve replacement.
  • the device systems and methods of the invention also facilitate intracardiac procedures such as repair of atrial or ventricular septal defects, electrophysiological mapping and ablation of the myocardium, electrophysiological mapping and ablation of the pulmonary veins, myocardial drilling, and other procedures.
  • delivery systems may be introduced through an opening into the heart or great vessel and advanced therefrom into vessels such as the coronary arteries to perform procedures such as angioplasty, atherectomy, coronary artery bypass grafting, or the pulmonary veins to perform procedures such as atrial fibrillation ablation.
  • An alternate aspect ofthe present invention is to provide a method of treating atrial fibrillation using a medical device with at least one radiofrequency electrode, the method comprising introducing the medical device through an intercostal penetration and an opening on a cardiac wall into a left atrium of a patient, wherein radiofrequency energy is provided through the at least one electrode to ablate at least one pulmonary vein in the left atrium.
  • a trocar may be placed at the intercostal penetration for the medical device to pass through.
  • the opening on the cardiac wall may be created by a delivery system having a delivery apparatus and a sharp-end inner medical device for creating said opening, the delivery apparatus comprising a cup balloon located at a distal section of said delivery apparatus configured for defining an isolated enclosure bordered by said cup balloon and said cardiac wall.
  • the delivery apparatus further comprises a plurality of suction ports located along a balloon rim of said cup balloon adapted for releasably securing said rim onto said cardiac wall.
  • a stentless and/or supportless atrioventricular valve comprising a singular membrane of tissue with at least two cusps and methods of delivery in a minimally invasive manner have been disclosed. While the invention has been described with reference to a specific embodiment, the description is illustrative of the invention and is not to be construed as limiting the invention. Various modifications and applications may occur to those who are skilled in the art, without departing from the true spirit and scope of the invention, as described by the appended claims.

Abstract

An atrioventricular valve intended for attaching to a circumferential valve ring and papillary muscles of a patient comprising a singular flexible membrane (20) of tissue or synthetic biomaterial, the valve having a sewing ring (10), an anterior cusp (52) and a posterior (51), wherein the anterior cusp and said posterior cusp are an integral part of a continuum from the singular membrane without sutured commissure between remote ends of the cusps and wherein texture elements (75) secured at edge portions of the cusps configured to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is sut

Description

DESCRIPTION
Atrioventricular Heart Valve and Minimally Invasive Delivery Systems Thereof
Field ofthe Invention The invention herein described relates to cardiac atrioventricular valves and minimally invasive delivery systems thereof.
Background ofthe Invention During normal physiological functions, the human heart valve opens up in response to the pressure of blood flow on its leaflets. The human heart valve also closes under the pressure exerted on the same leaflets when blood flow retrogrades. This physiological function of the heart valve prevents the backflow of blood in the heart. When the body is under no physical stress and the heart is beating at a normal resting state of about 70 beats per minute, the leaflets open by separation from one another and close by apposing each other, approximately 38 million times per year. It can be surmised that under stressful conditions or higher heart rates, the number of separations and appositions increases, as well as the force of impact between the leaflets.
Disease, congenital malformation, aging or trauma conditions can cause a natural heart valve to dysfunction. This may occur due to the decay, degeneration or disruption of the heart valve and/or its components. To restore proper functionality necessary for the continuation of life, a prosthetic heart valve is used to repair or replace the natural heart valve. Characteristics of a typical prosthetic heart valve may include hemodynamic performance, thrombogenicity, durability and ease of surgical implantation.
The shape of the leaflet and surrounding elements of a valve or a prosthetic valve apparatus is dependent on the function of the heart. In the past, numerous publications have taught that the valve shape directs the function of the heart. However, new paradigms have explained that it is the function of the heart that actually directs and defines the formation of the specific shape or form of the valve. This principle of "Form Follows Function" can now be used to produce new valvular mechanisms that more closely mimic the function ofthe native human heart valve. An atrioventricular valve, otherwise known as the mitral valve (in the left side of the heart) or the tricuspid valve (in the right side of the heart), is part of a continuum (referred to herein as the valve apparatus) that extends from the myocardium or muscular wall of the lower chambers, through the papillary muscles, the tendinous rope-like elements known as chordae tendinae, and the leaflets. There is a tricuspid valve apparatus in the right ventricular chamber, and more importantly the mitral valve apparatus within the left ventricular chamber, the pumping function of which provides the systemic flow of blood through the aorta to keep all tissues of the body supplied with oxygenated blood necessary for cellular function and life. These leaflets form a ring-like structure, known as the annulus, that is part ofthe heart's skeleton.
During a cardiac cycle, the valve apparatus functions as part of a unit composed of multiple interrelated parts, including the ventricular and atrial walls, the valve leaflets, the fibrous skeleton of the heart at the atrioventricular ring, and the subvalvular apparatus.
The subvalvular apparatus includes the papillary muscle within the ventricle, and the chordae tendinae which connect the papillary muscle to the valve leaflets.
The present practice of valvular surgery when the mitral valve alone is replaced after excision of the diseased mitral valve apparatus ignores the necessary contribution of the ventricular function. The ventricle and the apparatus work in unison to provide proper pumping to systemic or pulmonary circulation and proper arrest of blood return to the chambers ofthe atria.
Aortic and pulmonary valves have been replaced with simple trileaflet chemically treated biological valves obtained from animals, or bileaflet mechanical valves without extreme deficiencies in valvular or cardiac function. This is not the case when mitral or tricuspid valves are replaced and the necessary involvement of chordae tendinae and muscular elements of the chamber wall are not united to function in harmony with the valve leaflets. Those valves used in the aortic position cannot alone replace the mitral valve apparatus without anatomical and functional compromise.
Therefore, this requirement to maintain the continuum is of an absolute imperative nature for the mitral or tricuspid valve apparatuses.
In the past, attempts to generate the needed structure have met with difficulties. Thus, Aranguren Duo in U.S. Pat. No. 4,261,342, Gross in U.S. Pat. No. 5,662,704, and Gross in U.S. Pat. No. 5,824,067, incorporated herein by reference in their entirety, resort to use of a pig heart (porcine, swine) mitral valve to which a covering material is attached to the papillary heads around the chordae tendinae, in the form of a tube that provides an extension in order to fit and affix the valve to the papillary muscle remnants ofthe human heart after the diseased valve and subvalvular structure is excised and removed from the heart. This tube has to be trimmed until the proper dimension is found to connect the leaflets to the papillary remnants. However, trimming the tube during the surgery is necessary because the relation between annular size and chordal length are different in animal than in human hearts. Frater in U.S. Pat. No. 5,415,667 teaches an apparatus with a trapezoidal annulus possessing a rigid side. To this trapezoidal annulus are attached four separate leaflets joined together by sutures to provide an occluding surface to the flow of blood during the systolic or ejection phase of the cardiac cycle. The chordae are separate chords attached by sewing to the edge portion of the leaflets. At times, these are integral in the four separate cusps and are each attached by sewing the other tliree cusps. All four cusps and their respective chordal attachment portions and flange portions are formed as separate components for fitting to a basic ring element having a trapezoidal opening. The sutured attachment portions render the cusp less flexible as compared to a natural cusp without sutures. Machuraju in U.S. Pat. No. 5,554,184 discloses cutting two leaflets that are then sutured together to form a bileaflet valve. Similarly, Deac in U.S. Pat. No. 5,344,442 and U.S. Pat. No. 5,500,015, entire disclosures of which are incorporated herein by reference, teaches a means for cutting sections of biological material and joins them by sutures to form a bileaflet mitral valve. The sutured joint portion becomes stiff and less flexible. There is a clinical need to fabricate a bileaflet or trileaflet valve with sutureless joint portion or commissure; preferably to have the valve made from a singular membrane of tissue or artificial sheet.
All of the aforementioned patents teach of a form made by stitching various sections of material and expecting that the form will be able to profile the function. This leads Cox in U.S. Pat. No. 6,270,526 to pronounce his principle of "Form Follows Function." He notices that the human fetus while in its early stages (about 25 days of gestation) in titer o that further exhibits tubular connections between the fetal heart gestational developments that will produce the structure. This "Form Follows Function" is the paradigm that must be used in order to fabricate a heart valve that will very closely identify with the human heart valve.
Current Options for Tissue Heart Naive Replacement Most tissue valves are constructed by sewing the leaflets of pig aortic valves to a stent to hold the leaflets in proper position as a stented porcine valve. They may also be constructed by removing valve leaflets from the pericardial sac of cows or horses and sewing them to a stent as a stented pericardium valve. The stents may be rigid or slightly flexible and covered with cloth (usually a synthetic material sold under the trademark Dacron™ or Teflon™) and attached to a sewing ring for fixation to the patient's native tissue. In one embodiment, the porcine, bovine or equine tissue is chemically treated to alleviate any antigenicity.
A stentless valve prosthesis generally comprises a biological valve having a suture ring, anchoring skirts at the commissures ofthe valve, and an outer polyester covering. A stentless valve prosthesis secured or supported to the native valve annulus and leaflets reduces tissue stress as the flexible valve prosthesis adapts and conforms to the native valve, so that durability and resistance to wear and calcification are improved.
The main advantage of tissue valves is that they do not cause blood clots to form as readily as do the mechanical valves, and therefore, the tissue valves do not typically require lifelong systemic anticoagulation measures. However, the presence of the stent and sewing ring prevents the tissue valve from being anatomically accurate in comparison to a normal human heart valve.
Principles of Tissue Heart Naive Construction Cox in U.S. Pat. No. 6,270,526, No. 6,092,529, No. 5,824,063, No. 5,713,950, and No. 5,480,424, incorporated herein by reference in their entirety, teaches the "Function Follows Form" principles of tissue heart valve construction. Under the best of circumstances (i.e., replacement of the aortic valve), the construction of artificial tissue valves has been based on the concept that if the artificial valve can be made to approximate the anatomy (form) of the native valve, then the physiology (function) of the artificial valve will also approximate that of the native valve. This is the concept that "Function Follows Form." For example, the manufacturers of all artificial porcine valves first re-create the form of a native human aortic valve by: 1) harvesting a porcine aortic valve, 2) fixing it in glutaraldehyde or other suitable fixatives to eliminate antigenicity, and 3) suturing the porcine valve to a stent to hold the three leaflets in place. In other words, the primary goal in the construction of these artificial valves is to reproduce the form of the human aortic valve as closely as possible. The assumption is made that if the artificial valve can be made to look like the human aortic valve, it will function like the human aortic valve (i.e., proper function will follow proper form). The same assumption is also followed for commercially available pericardial valves. In the case of mitral or tricuspid valve replacement, even the dubious concept of
"function follows form" has been discarded since the same artificial valves that are designed to look like the aortic valve are used to replace the mitral and tricuspid valves.
In other words, no attempt at all is made to reproduce even the form of these native valves, much less so their function.
Thus, in the case of artificial valves to be used for aortic valve replacement, the dubious concept of "function follows form" has dictated the construction of all artificial tissue valves during the 30 years of their development and use. Even worse, no discernable underlying concept at all has been used in terms ofthe artificial valves used to replace the mitral and tricuspid valves.
The "Function Follows Form" concept has several limitations and appears to be a fundamental shortcoming which underlies the present construction of all artificial tissue valves. In the first place, it simply is not possible to recreate the exact anatomy (form) of a native heart valve utilizing present techniques. Although homograft (human cadaver) and porcine aortic valves have the gross appearance of native aortic valves, the fixation process (freezing with liquid nitrogen, and chemical treatment, respectively) alters the histological (microscopic) characteristics of the valve tissue. Porcine and bovine pericardial valves not only require chemical preparation (usually involving fixation with glutaraldehyde), but the leaflets must be sutured to cloth-covered stents in order to hold the leaflets in position for proper opening and closing of the valve. A recent advance has been made in this regard by using "stentless" porcine valves that are sutured or supported directly to the patient's native tissues for aortic valve replacement, but the problem of chemical fixation remains. In addition, these stentless artificial valves cannot be used for mitral or tricuspid valve replacement. Perhaps the major limitation of the "Function Follows Form" concept is that no efforts have been made previously to approximate the form of either the mitral valve or the tricuspid valve. If animal tissue valves are used to replace either of these native valves, the tri-leaflet porcine aortic valve prosthesis or the tri-leaflet bovine pericardial valve prosthesis is normally used. In doing so, even the faulty concept of "Function Follows Form" is ignored, since there are no artificial valves available for human use that approximate the anatomy (form) ofthe native mitral or tricuspid valves. Percutaneous Intercostal Penetration Various surgical techniques may be used to repair a diseased or damaged valve, including annuloplasty (contracting the valve annulus), quadrangular resection (narrowing the valve leaflets), commissurotomy (cutting the valve commissures to separate the valve leaflets), shortening mitral or tricuspid valve chordae tendinae, reattachment of severed atrioventricular valve chordae tendinae or papillary muscle tissue, and decalcification of valve and annulus tissue. Alternatively, the valve may be replaced, by excising the valve leaflets of the natural valve, and securing a replacement valve in the valve position, usually by suturing the replacement valve to the natural valve annulus. A conventional procedure for approaching the left atrium is by intravascular catheterization from a femoral vein through the cardiac septal which separates the right atrium and the left atrium. This intravascular procedure is not only dangerous and tedious because of its long, tortuous route, but is also of limited use because of the catheter size suitable for insertion intravascularly. Sterman et al. in U.S. Pat. No. 6,283,127, entire contents of which are incorporated herein by reference, discloses a device system and methods facilitating intervention within the heart or great vessels without the need for a median sternotomy or other form of gross thoracotomy, substantially reducing trauma, risk of complication, recovery time, and pain for the patient. Using the device systems and methods of the invention, surgical procedures may be performed through percutaneous penetrations within intercostal spaces of the patient's rib cage, without cutting, removing, or significantly displacing any of the patient's ribs or sternum. The device systems and methods are particularly well-adapted for heart valve repair and replacement, facilitating visualization within the patient's thoracic cavity, repair or removal of the patient's natural valve, and, if necessary, attachment of a replacement valve in the natural valve position.
Of particular interest in the present application are techniques for the implantation of an atrioventricular valve that can be retracted or folded inside a delivery system or cannula for delivery through a less-invasive intercostal penetration to the desired place, particularly in a left atrium. Thereafter, the retracted valve is released, expanded, separated from the delivery system, and secured to the desired place with a minimally invasive technique. The same minimally invasive system can also deliver a medical device for drug delivery, energy delivery, and tissue ablation, among other applications.
Therefore, it would be desirable to provide a delivery system for delivering therapeutic means in a patient's heart comprising a heart valve configured to be releasably folded inside a lumen of the delivery system through a percutaneous intercostal penetration of a patient's chest. The therapeutic means may also comprise a medical device that has radiofrequency or cryo-energy ablation capability.
One aspect of the present invention is to fabricate a stentless and/or supportless atrioventricular valve and a delivery system thereof that avoids the aforementioned disadvantages, wherein the valve comprises a singular membrane of biocompatible material that has at least two cusps configured to form a substantially tubular shape for use as an atrioventricular valve, and wherein the delivery system comprises a short apparatus for approaching the left atrium through a percutaneous intercostal penetration.
Summary ofthe Invention One aspect of the present invention is to provide a stentless and/or supportless atrioventricular valve comprising a singular membrane of tissue or plastic material. In one embodiment, the valve has a sewing ring and at least two cusps hinged continuously from the inner opening ofthe sewing ring, wherein the cusps are an integral part of a continuum from the singular membrane configured or conformed to form a substantially tubular shape for use as an atrioventricular valve, hi one embodiment, the substantially tubular form ofthe disclosed atrioventricular valve follows the "Function Follows Form" concept.
Another aspect of the present invention to fabricate a stentless and/or supportless atrioventricular valve with a singular membrane of tissue biomaterial that is chemically treated to reduce its antigenicity. Alternately, the singular membrane of biomaterial ofthe present invention is a synthetic plastic.
Another aspect ofthe present invention to provide a method of forming a stentless and/or supportless atrioventricular valve intended for attaching to a circumferential valve ring and papillary muscles of a patient comprising a singular membrane of biomaterial with at least two cusps, wherein either cusp has a semicircular tip edge joined by two generally straight side edges and wherein each straight side edge is trimmed and configured at an angle of about less than 20 degrees from a reference imaginary central longitudinal line of that cusp.
A preferred aspect of the present invention is to provide a delivery system and methods for minimally invasively delivering a medical device or an atrioventricular valve into the anterior of a patient's heart. In one embodiment, the delivery system has a securing mechanism for maintaining the system at a desired place during the operation, wherein the securing mechanism may comprise a plurality of vacuum suction elements associated with an inflatable balloon.
In one embodiment, the sewing ring of the atrioventricular valve is made from a continuum of the singular membrane or is further reinforced by a sewing ring element to enhance the attachment of the sewing ring onto a heat valve annulus of a patient, hi an alternate embodiment, the sewing ring element is made of a biocompatible material selected from a group consisting of non-biodegradable plastic material, biodegradable plastic material, non-biodegradable biological material, biodegradable biological material, and the like. In another embodiment, the cusps further comprise texture element(s) at an edge portion of the cusps configured and adapted to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart. In a further embodiment, the texture elements may be made of polyester, polytetrafluoroethylene fabric, polyurethane, silicone, or other suitable fabrics.
A further aspect ofthe invention is to provide a delivery system for accessing a left atrium of a patient through a cardiac wall, the delivery system comprising a cup balloon located at a distal section of the delivery system, wherein the cup balloon has a balloon rim configured for defining an isolated enclosure bordered by the balloon rim of the cup balloon and the cardiac wall.
Brief Description ofthe Drawings Additional objects and features ofthe present invention will become more apparent and the invention itself will be best understood from the following Detailed Description of Exemplary Embodiments when read with reference to the accompanying drawings. FIG. 1 is a sewing ring element comprising essentially flat side surfaces to be wrapped within a singular membrane of biomaterial for valve fabrication.
FIG. 2 is a singular membrane of biomaterial having a hole at about a central region ofthe membrane adapted for valve fabrication ofthe present invention.
FIG. 3 is another embodiment of the present invention comprising a pre-trimmed singular membrane of biomaterial having a hole at about a central region ofthe membrane adapted for valve fabrication. FIG. 4 is a first step ofthe valve fabrication by laying a sewing ring element on top ofthe singular membrane of biomaterial.
FIG. 5 is a next step of the valve fabrication by wrapping a singular membrane around the sewing ring element. FIG. 6 is a further step of the valve fabrication by inverting a periphery of the singular membrane through an opening ofthe sewing ring element.
FIG. 7 is another step of the valve fabrication by securing the singular membrane onto the sewing ring element.
FIG. 8 is one further step ofthe valve fabrication by aligning the potential wrinkles or folds adj acent the remote ends portion of the cusps.
FIG. 9 is still another step of the valve fabrication by trimming the cusps at a desired angle with reference to an imaginary central straight line of the cusp, wherein the valve is shown at an open position.
FIG. 10 is a cross-sectional view of section I - I of FIG. 8, illustrating the distal portion of a cusp comprising texture elements at edge portions of the cusps configured to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart.
FIG. 11 is the atrioventricular valve shown at a close position.
FIG. 12A is a perspective view of an atrioventricular valve following the blood flow direction.
FIG. 12B is a perspective view of an atrioventricular valve against the blood flow direction.
FIG. 13 is a delivery system of the present invention for minimally mvasively deploying a medical device to the interior of a body. FIG. 14 is a cross-section view of the distal portion of a delivery system according to the principles ofthe present invention.
FIG. 15 is a front cross-sectional view of section II - II of FIG. 14, illustrating a cup balloon element with suction capability. FIG. 16 is a preferred embodiment of the atrioventricular valve that is constrained with a minimal profile during a minimally invasive deployment stage.
FIG. 17 is an illustrative view of a medical device being delivered to an interior of a body via a minimally invasive manner.
Detailed Description ofthe Preferred Embodiments Referring to FIGS. 1 to 17, what is shown is an embodiment of a stentless and/or supportless atrioventricular valve and a delivery system thereof comprising a singular membrane of tissue or plastic biomaterial. Most conventional heart valves are manufactured as stented valves. In the last few years, stentless heart valves with more flexible annular rings are available; however, those valves are still typically supported by sutures or clothes on the valve and/or between the cusps and the valve base. A commercially available pericardium valve made by suturing leaflets together to form a valve is not a "supportless valve" according to the present invention.
One embodiment of the invention relates to the "supportless" atrioventricular valve. The supportless atrioventricular valve is comprised of an anterior cusp and a posterior cusp, each cusp having two generally straight side edges that are joined at a semicircular tip edge, wherein each ofthe straight side edges is trimmed and configured at an angle of about 20 degrees or less, preferably between a range of 15 to 20 degrees, from a reference central longitudinal line ofthe cusp. The supportless atrioventricular valve has no additional support, such as a conventional stenting element made of metal or plastic material. The supportless atrioventricular valve is quite feasible for delivery to an implant site by a minimally invasive manner. hi another embodiment, a stentless atrio entricular heart valve made of a singular flexible membrane is described as follows. FIG. 1 shows a sewing ring element comprising essentially flat or straight side surfaces to be wrapped within a singular membrane of biomaterial for valve fabrication of the present invention. A sewing ring element 10 having a general configuration of circular, oval shape, D-shape, or other convenient shape may be made of rigid, semi-rigid or flexible biomaterial from synthetic polymer or biological tissue. In one embodiment, the sewing ring element 10 in FIG. 1 comprises a first top surface 12 bordered by a first inner edge (that is, the inner perimeter) 14 defining the ring opening 11 and a first outer edge 13 (that is, the outer perimeter), a second bottom surface 15 opposite of the first surface 12, wherein the first surface 12 and the second surface 15 are connected by a supporting member of the sewing ring element 10. The second surface 15 is bordered by a second inner edge (that is, perimeter) 16 defining the bottom ring opening 9 and a second outer edge or perimeter 17.
In one embodiment, the ring opening 11 at the first top surface 12 is identical in shape and size to the bottom ring opening 9. The ring 10 is conformed suitable for suturing or securing onto another material, such as a-singular flexible membrane 20 of the present invention, h a particular embodiment, the configuration or shape ofthe first inner edge 12 may not necessarily match that of the second inner edge 16 while the configuration or shape of the first outer edge 13 may not necessarily match that of the second outer edge 17. The sewing ring opening of the present invention may be "D" shaped and matched by a correspondingly larger D-shaped external profile suitable for placing the atrioventricular valve in a patient heart. A circular, oval shaped or D-shaped ring opening that is flexible for replacing an atrioventricular valve is well known to a cardiac surgeon or skilled artisan.
The sewing ring element 10 further comprises an inner perimeter 14 including at least a straight side portion 19 thereof and an outer perimeter 13 having a straight side portion 18. The side portions 18, 19 may also be a non-straight configuration. In another alternate embodiment, the cross-section configuration of a sewing ring element may be square, circular, oval, D-shaped, trapezoidal, or other irregular shape.
In an illustrative embodiment, the sewing ring element may be made of a biocompatible material selected from a group consisting of non-biodegradable plastic material, biodegradable plastic material, non-biodegradable biological material, or biodegradable biological material. The sewing ring element may be textured, porous, or constructed of fabric components suitable for valve fabrication. hi the supportless atrioventricular valve embodiment, the sewing ring element of the present invention may be a virtual element or a temporary template. The "virtual element" is herein intended to mean an imaginary non-existing element that aids in better describing and assisting the valve fabrication process. The sewing ring element as a temporary template aid is intended to simplify the valve fabrication process, followed by disengaging the template from the finished valve. One example ofthe temporary template is made of a liquid soluble substance that is disengaged from the valve by dissolution or biodegradation.
FIG. 2 shows a singular membrane of biomaterial having a hole 26 with its border or perimeter 27 at about a central region of the membrane and a periphery region 35 (shown in FIG. 5) adapted for valve fabrication. The singular flexible membrane 20 has a first membrane surface 28 and an opposite second membrane surface 29. The surface property/morphology of the surface 28 may be similar or different to that of the opposite membrane 29. Typically, the membrane surfaces 28, 29 are relatively smooth for intended valve fabrication purposes. In one embodiment, the membrane 20 is shaped like a typical rectangular singular sheet that is bordered by four edges 22, 23, 24, and 25 that are part of the periphery 35. In an alternate embodiment, the membrane may shape circularly, irregularly without recognizable edges, or in a special design configuration. The membrane 20 may be selected from biological tissue, a synthetic polymer or a synthetic protein matrix. The membrane of biological tissue may be chemically treated to reduce its antigenicity. The chemicals for treating biological tissue may include glutaraldehyde, formaldehyde, dialdehyde starch, polyepoxy compounds, or the like that are well known to one who is skilled in the art of chemical treatment. Further, the membrane of tissue may be pericardium tissue selected from a group consisting of equine, bovine, porcine, ovine, human, or other animals. The thickness of tissue membrane is preferred to be in the range of less than 0J mm up to about a few millimeters. The singular membrane 20 made of synthetic polymer may be selected from a group consisting of polyurethane, silicone, expanded polytetrafluoroethylene, fluoro-polymer, polyester, polyethylene, polypropylene or co-polymer thereof. The singular membrane of the present invention has adequate strength or mechanical properties suitable as a heart valve construct. h an alternate embodiment, the singular flexible membrane may be pre-trimmed and shaped for a valve fabrication. FIG. 3 shows another embodiment of the present invention comprising a precut (that is, pre-trimmed) singular membrane 2 of biomaterial having a hole 3 at about a central region of the membrane adapted for valve fabrication. In one illustrative embodiment, the membrane 2 comprises a first major cusp member 4, a second major cusp member 5, a third minor cusp member 6, and a fourth minor cusp member 7. All cusp members are so pre-trimmed that the final fabricated configuration is suitable as a stentless and/or supportless atrioventricular valve apparatus. The first major cusp member 4 has a first side edge 4A, an opposite second side edge 4B, and a first end edge 4C, and a second end edge 4D. Further, the first major cusp member 4 has a first trimmed edge 4E and a second trimmed edge 4F. Similarly as shown in FIG. 3, the second major cusp member 5 has a first side edge 5 A, an opposite second side edge 5B, and a first end edge 5C, and a second end edge 5D. Further, the second major cusp member 5 has a first trimmed edge 5E and a second trimmed edge 5F. Not all edges ofthe major cusp members 4, 5, or the minor cusp members 6, 7 are straight. The edges may be essentially straight or in other suitable curvature suitable for making the intended valve of the present invention. A first group of the trimmed edges 4E, 5E ofthe present invention is trimmed and configured at an angle (θ) of about less than 20 degrees from a reference central longitudinal line and adapted to be a constituent of the posterior cusp 51 (as shown in FIG. 9). Similarly, the second group ofthe trimmed edges 4F, 5F ofthe present invention is trimmed and configured at an angle (β) of about less than 20 degrees from a reference central longitudinal line and adapted to be a constituent of the anterior cusp 52 (as shown in FIG. 9). The angle θ or β may preferably be in the range of about 15 to 20 degrees.
As shown in FIG. 3, the third minor cusp member 6 has two side edges 6 A, 6B and an end edge whereas the fourth minor cusp member 7 has two side edges 7A, 7B and an end edge. As stated, any edge may be essentially straight or in other suitable curvature suitable for making the intended valve ofthe present invention.
To fabricate a stentless and/or supportless cardiac valve of the present invention, a hole 26 is created at about the center of the membrane 20, wherein the hole 26 (so-called the membrane opening) has a perimeter 27 that substantially matches the second inner edge or perimeter 16 of the ring element 10. FIG. 4 shows a first step of the valve fabrication by laying a sewing ring element 10 on top of the singular membrane 20 of biomaterial so as to substantially match the second ring opening 9 against the membrane opening 26. In an alternate fabrication process using a virtual element, this first step is skipped. A plurality of sutures (either temporary sutures or permanent sutures) 31, 32, 33 or other securing mechanisms to fasten the membrane 20 onto the ring 10 are secured evenly at along the contacting zone between the membrane 20 and the second ring surface 15.
Thereafter, all edges (for example, edges 22, 23, 24, and 25 in FIG. 2; or the cusp members 4, 5, 6, and 7 in FIG. 3) or the periphery region 35 of the membrane 20 are picked up so as to wrap over the second bottom surface 15 of the ring 10 and to continue wrapping around the second outer edges 17, the outer straight side portion 18, and the first outer edge 13 of the sewing ring element 10. In one embodiment, FIG. 5 shows a picked- up membrane with the second membrane surface 29 facing exteriorly while the first membrane surface 28 facing interiorly. The periphery region portion 35 where all edges are picked and pulled close to each other is located at about the very top of the combined structure of the ring element 10 and membrane 20. FIG. 5 shows a next step of the valve fabrication by wrapping a singular membrane around the sewing ring element 10.
FIG. 6 shows a further step of the valve fabrication by inverting the periphery 35 of the singular membrane through an opening 11 of the sewing ring element 10 so as to form a complete wrapping around the ring element 10. In other words, the singular membrane 20 hereby wraps over the first surface 12 ofthe ring element 10 and to continue wrapping around the first inner edge 14 and the second inner edge 16 of the sewing ring element 10. In one embodiment, FIG. 6 shows a fully wrapped membrane with the first membrane surface 28 facing exteriorly while the second membrane surface 29 facing interiorly. The portion ofthe membrane-covered sewing ring element is also known as the sewing ring 21 of the atrioventricular valve to be secured to the valvular annulus of a patient. There may be a few wrinkles or folds 38, 39 at about the sewing ring 21 as a result of inverting the membrane 20 through the ring element opening 11. FIG. 7 shows another step of the valve fabrication by securing the singular membrane onto the sewing ring element. To configure the singular membrane 20 more suitable as a functional cardiac valve ofthe present invention, the membrane 20 is slightly stretched and re-positioned over the ring 10 so that essentially all the wrinkles 38, 39 are grouped at two opposite ends 36, 37 of the ring element 10. In other words, the majority portion ofthe membrane 20 over the ring element 10 away from the two opposite ends 36, 37 is essentially free of wrinkles.
As shown in FIG. 7, a plurality of sutures 41, 42, 43 or other securing mechanisms are placed substantially equally spaced at along the contacting zone of the membrane and the first ring surface 12. One embodiment of securing the membrane onto the ring element is to suture or stitch the membrane at the second surface 15 to the membrane at the first surface 12 by passing a suture through the ring 10 itself. In the "supportless" embodiment, the ring 10 is to subsequently dissolved after assembly so that a derived sewing ring 21 is made ofthe membrane material alone.
FIG. 8 shows one further step of the valve fabrication by aligning the potential wrinkles adjacent the remote ends portion of the cusps, whereas FIG. 9 shows still another step of the valve fabrication by trimming the cusps at a desired angle with reference to an imaginary central straight line of the cusp(s). This trimming step may be omitted and substituted by a pre-trimmed singular membrane 2 as shown in FIG. 3.
By following the above-described procedures, a stentless and/or supportless atrioventricular valve can also be fabricated from a pre-trimmed singular membrane 2. The periphery portion (including cusp members 4, 5, 6, and 7) of the membrane 2 is inverted and passes through the ring opening 11 of the sewing ring element 10. The edge pairs (for example, a pair of edges 4B and 6B; a pair of edges 5B and 6A; a pair of edges 5A and 7A; and a pair of edges 4A and 7B) are secured together to form a substantially tubular shape for use as the atrioventricular valve apparatus. In one embodiment, the posterior cusp may comprise the cusp member 7 and its adjacent secured portions of the cusp members 4 and 5. Similarly, the anterior cusp may comprise the cusp member 6 and its adjacent secured portions ofthe cusp members 4 and 5. The cusp members 4 and 5 are trimmed essentially symmetrical; i.e., the edges 5C, 5D, 5E, and 5F are equivalent counterparts ofthe edges 4C, 4D, 4E, and 4F, respectively.
FIG. 9 shows a stentless and/or supportless sewing ring 21 with a trimmed membrane. In one illustration of a bi-leaflet valve, the periphery portion 35 is trimmed and configured to include a posterior cusp 51 and an anterior cusp 52. The sewing ring 21 of the present invention comprises an opening defined by a perimeter including at least a first and a second straight side portions thereof. An anterior cusp 52 is configured hinged continuously from the first straight side portion while a posterior cusp 51 is configured hinged continuously from the second straight side portion opposite the anterior cusp 52, wherein the anterior cusp and the posterior cusp are an integral part of a continuum from the singular membrane 20 with a common commissure between remote ends 61 of the anterior cusp 52 and the posterior cusp 51. Collectively, the anterior cusp 52 and the posterior cusp 51 are carried over from the outer surface 18 ofthe sewing ring element 10 and then hinged continuously along the inner surface 19.
As shown in FIG. 9, the membrane-covered sewing ring 21 is formed by an inverted flange portion of the combined cusps 51, 52 located at about the sewing ring place 21 that is configured to shape the sewing ring opening, wherein the flange portion from the cusps 51, 52 is an integral part of a continuum from the singular membrane 20.
The atrioventricular valve of the present invention may further comprise a third cusp located between the anterior cusp 52 and the posterior cusp 51, wherein the third cusp hinged continuously from a third straight side portion of the perimeter 14 and wherein the third cusp is an integral part of a continuum from the singular membrane 20 without sutured commissure between any two remote ends of the anterior cusp, the posterior cusp and the third cusp. A cardiac valve with two cusps (that is, a bileaflet valve) or three cusps (that is, a trileaflet valve) is well known to an ordinary cardiac surgeon or one who is skilled in the art.
The anterior cusp 52 or the posterior cusp 51 of the atrioventricular valve of the present invention has a generally semicircular or curved edge portion to enable it projecting deeply into the ventricle cavity when the sewing ring 21 is sutured to an atrioventricular junction of a patient heart. In one embodiment as illustrated in FIG. 8, the anterior cusp 52 has a semicircular or curved tip edge 65 and two generally straight side edges 63, 64 that are joined at the tip edge 65, wherein each (63 or 64) of the straight side edges is trimmed and configured at an angle (β) of about less than 20 degrees from a reference central longitudinal line 66 ofthe anterior cusp 52 (FIG. 9). Similarly, in another embodiment as illustrated in FIG. 8, the posterior cusp 51 may have a semicircular or curved tip edge 55 and two generally straight side edges 53, 54 that are joined at the tip edge 55, wherein each ofthe straight side edges 53, 54 is trimmed and configured at an angle (θ) of about less than 20 degrees from a reference central longitudinal line 67 ofthe anterior cusp 51 (shown in FIG. 9). The edges at about the cusp joint 61 is so trimmed and configured to exert certain degree of tension for proper valve close and open operations. This tensioned cusp joint 61 is equally true for the case of using a pre-trimmed singular flexible membrane 2.
FIG. 10 shows a cross-sectional view of section I - I of FIG. 8, illustrating the distal portion of a cusp comprising texture elements at edge portion(s) of the cusps configured to extend the texture element(s) for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart. For illustration purposes, a portion ofthe posterior cusp 51 is further shown in FIG. 10 to indicate a plurality of optional openings 73, 74 and an end region 72 of the posterior cusp 51 covered with a texture element 75 made of silicone rubber (Silastic™), cloth (usually Dacron™), or cloth coated with polytetrafluoroethylene (Teflon™) or other fabric. A conventional method of securing the texture element onto the cusp may include bonding, stitching, gluing, suturing or the like.
In an alternate embodiment starting with a pre-trimmed singular membrane 2, the cusp member 7, the right-side portion of the cusp member 4, and the right-side portion of the cusp member 5 are to be joined to fomi the posterior cusp 51 shown in FIG. 10, wherein the cusp members 76, 77, and 78 in FIG. 10 are equivalent counterparts of those referred above. The remote portions 72 ofthe cusp members 76, 77, 78 are joined by the texture element 75. The remaining portions of the edges of the cusp members 76, 77, 78 away from the remote portions 72 may not be secured together and thus may form the openings such as 73, 74.
In securing together the three cusp members of the membrane 2 to form either a posterior cusp or an anterior cusp, more tension is applied to the edge 4E rather than the opposite edge 4A (FIG. 3). This higher tension is generally true for the edges 4F, 5E, and 5F than their conesponding opposite edges 4B, 5A, and 5B, respectively during the valve fabrication process. As a result of appropriate tension arrangements to each individual edge and cusp members, the finished cusp 51 is configured to have lower tension on the cusp member 77 as compared to the adjacent cusp members 76 and 78 and enables the cusps 51, 52 of the present invention to function as a competent atrioventricular heart valve.
The anterior cusp 52 and/or the posterior cusp 51 of the present invention may comprise texture elements at edge portions of the cusps configured to extend the texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is secured to an atrioventricular junction of a patient's heart. The anatomy of the atrioventricular valves and the subvalvular apparatus of a patient can be found in any medical reference textbook (for example, MITRAL NALNE, edited by H Boudoulas and CF Wooley, published by Futura Publishing, ΝY 2000). The texture elements are formed integral with the cusps 51, 52 and are provided with integral attachment portions at ends 72 remote from the cusps for suturing to the papillary muscles, h one embodiment, the supportless atrioventricular valve apparatus is secured at an atrioventricular junction using a dissolvable or biodegradable material.
Angelini and associates (Anatomy ofthe Mitral Valve in MITRAL NALNE, edited by H Boudoulas and CF Wooley, published by Futura Publishing, ΝY 2000), entire contents of which are incorporated herein by reference, teach the mitral valvar complex being attached proximally at the left atrioventricular junction and, distally, through the papillary muscles, to the myocardial wall of the left ventricle. Proper action of the complex depends on normal function and integration of each of the components. Therefore, it is one object of the present invention to provide an atrioventricular valve fabricated from a singular flat membrane of biomaterial adapted to mimic the natural mitral function.
The general configuration of either the posterior cusp 51, the anterior cusp 52 or the third cusp in a trileaflet valve apparatus may be slightly concave to exhibit adequate support when secured to the papillary muscles in a ventricle cavity upon deployment.
FIG. 9 shows an atrioventricular valve at an open position while FIG. 11 shows the valve at its close position. At a valve close position, the ventricle is contracted. The cusp is under quite tension because the remote end of the cusps is still attached to the papillary muscle. The cusps joint section 61 so constructed according to the principles of the present invention enables the valve to close promptly at systole. FIG. 12A shows a perspective view of an atrioventricular valve following the blood flow direction (that is, the valve is open), while FIG. 12B shows a perspective view of an atrioventricular valve against the blood flow direction (that is, the valve is closed). During an atrial relaxation phase, the atrioventricular valve cusps are open toward to the ventricle cavity along with the blood flow direction (arrow 57). During a ventricular contraction phase, the atrioventricular cusps tend to push back against the blood flow direction (arrow 58). The atrioventricular valve according to the present invention may also be flexible and retractable/foldable within a delivery apparatus for minimally invasive delivery purposes. FIG. 13 shows a delivery system of the present invention or delivery means for minimally mvasively deploying a medical device to the interior of a body, particularly through a percutaneous intercostal penetration. It is one aspect ofthe invention to provide a method for minimally mvasively delivering an atrioventricular valve made of a singular membrane of tissue into a patient comprising folding said valve within a lumen of a delivery system or delivery means for delivering through a cardiac wall into a left atrium of the patient. The delivery system (also known as "delivery means" for delivering a medical device into a body of a patient) may comprise a delivery apparatus 80 and an inner medical device 107 that is slidably inserted within a lumen 95 of the delivery apparatus 80, wherein the inner medical device may serve as the delivery means for delivering the atrioventricular valve ofthe present invention.
The "inner medical device" of the present invention is meant to indicate a device that could be inserted through a lumen ofthe delivery apparatus 80 for advancing into an interior cavity or a patient's heart for therapeutic or diagnostic purposes, including delivering a heart valve, delivering energy to treat tissue, delivering a drug, or the like. A delivery system of the present invention comprises a delivery apparatus 80 having a shaft 89, the shaft 89 having a distal end 81, a distal opening 88A, a proximal end 82, and at least one lumen 95 between the distal end 81 and the proximal end 82. The delivery apparatus 80 also comprises a distal section 83 that is used to releasably secure the distal end 81 at about a cardiac wall during delivering the inner medical device. The delivery apparatus 80 comprises a handle or handpiece 84 that is attached to the proximal end 82 of the shaft 89. The delivery apparatus 80 also comprises a fluid infusion system 85 with a fluid infusion control mechanism 85A for inflating a cup balloon 90 (see FIG. 14) securely attached at the distal section 83 of the apparatus 80. Further, the apparatus 80 comprises a suction mechanism 86 with a suction control mechanism 86A for releasably attaching the cup balloon 90 onto the cardiac wall of a patient. The "cup balloon" of the present invention is a cup, cone, or half-a-ball shape configured for defining an isolated enclosure bordered by the balloon rim of the cup balloon and the cardiac wall. There is an elongated lumen 95 within the delivery apparatus 80 having a distal opening 88A and a proximal opening 88B, wherein a proximal receiving element 87 on the apparatus 80 with a locking mechanism 87A is for introducing an inner medical device 107 ofthe present invention into the interior cavity of a patient's heart. The atrioventricular valve of the present invention is generally characterized by its softness and collapsibility radially for delivery by the inner medical device 107. The delivery apparatus 80 may be made from plastic material, metal or composite material. In one embodiment, the delivery apparatus may be made ofthe material selected from the group consisting of polyethylene, polypropylene, polycarbonate, nylon, polytefrafluoroethylene, polyurethane, stainless steel, Nitinol, titanium, polyimide, polyester, and the like. Similarly, the inner medical device may be made of the material selected from the group consisting of polyethylene, polypropylene, polycarbonate, nylon, polytetrafluoroethylene, polyurethane, stainless steel, Nitinol, titanium, polyimide, polyester, and the like.
FIG. 14 shows a cross-section view of the distal section 83 of the delivery apparatus 80 of a delivery system according to the principles of the present invention, h one embodiment, after the apparatus 80 is delivered to adjacent a desired location at the cardiac wall, the rim of the cup balloon 90 in a circular or continuous loop manner is deployed and the suction ports 93 are activated so that the outermost rim 99 in a circular or continuous loop manner of the cup balloon 90 is firmly and suckedly attached to the cardiac wall, defining an attachment rim surface bordered by a balloon inner wall 92B and a balloon outer wall 92A. The inflating fluid is infused to the balloon 90 via a fluid passageway 91 which is a part ofthe overall fluid infusion system 85.
The cup balloon 90 in FIG. 14, upon being inflated, defines a cup-like enclosure or compartment that is isolated from the surrounding environment. The balloon may be made of any typical elastomeric material, such as silicon, latex, polyurethane, mixture or copolymer thereof, or the like. Like a party balloon, when the balloon 90 is inflated, the balloon tends to expand both radially and longitudinally outwardly (shown by an arrow 98). The balloon construction and its use as balloon angioplasty in cardiovascular applications are well known to one who is skilled in the art. The cup balloon of the delivery system is preferably inflated with a saline solution to avoid the possibility of introducing into the patient an air embolism in the event that the balloon ruptured. The balloon should be inflated to a pressure sufficient to form an isolated enclosure to prevent outflow of blood into the surrounding. An intermediate pressure in the order of 10 mmHg to 100 mmHg or more is preferable. The suction or vacuum pressure for the plurality of suction ports is generally in the range of -5 to -100 mmHg.
FIG. 15 shows a front cross-sectional view of section II - II of FIG. 14, illustrating the balloon 90 with a plurality of suction ports 93 at its rim 99. Each suction port 93 is connected to the suction mechanism 86 via a suction passageway 94 individually or collectively.
The stentless and/or supportless atrioventricular valve 21 of the present invention may be folded inside a lumen 97 of the inner medical device 107 as shown in FIG. 16.
Other folded shapes or folding/retraction patterns of an implant, including the atrioventricular valve 21, inside the inner medical device 107 is also within the scope of the present invention.
FIG. 17 shows an illustrative view of an inner medical device 107 being delivered to the left atrium 106 of a patient, wherein the patient's heart 100 is positioned to show the left atrium 106 and atrium wall 101. hi operation, the delivery apparatus 80 of a delivery system of the present invention having a cup balloon arrangement 90 at the distal section of the delivery apparatus 80 is deployed through a percutaneous intercostal penetration. The delivery apparatus 80 may be introduced through a cannula or trocar 104 positioned in one of percutaneous intercostal penetrations, the cannula or trocar having a proximal end disposed outside of the patient and a distal end disposed within the chest. A general minimally invasive procedure is well known to ordinary clinicians who are skilled in the art. Examples are U.S. Pat. No. 5,972,030 and No. 5,613,937 to Ganϊson et al, entire contents of which are incorporated herein by reference.
After the distal end 81 of the delivery apparatus 80 touches the cardiac wall (or in other cases, a pericardium sac wall), the cup balloon 90 is deployed for its balloon rim 99 to intimately contact the wall while suction or vacuum is applied to the suction ports 93 adapted for creating an isolated working enclosure about the distal section 83 of the apparatus 80. hi one embodiment, a first inner medical device of a sharp scalpel or having a sharp-end is introduced through the opening 88B to create a slit or opening on the wall (either pericardium sac wall, cardiac wall or both). The scalpel is thereafter removed from the delivery system. In a subsequent embodiment, a second inner medical device of an ablation catheter with at least one electrode may be introduced through the proximal opening 88B. The ablation catheter may be used to ablate one or more pulmonary veins for treating atrial fibrillation. U.S. Pat. No. 6,217,576, No. 6,241,727 and No. 6,290,697 co-invented by one of the applicants, the entire contents of which are incorporated herein by reference, teach a catheter probe and methods for treating focal atrial fibrillation in pulmonary veins. Treating atrial fibrillation by ablating one or more pulmonary veins is well known to an electrophysiologist who is skilled in the art.
The method for minimally invasively delivering a stentless and/or supportless atrioventricular valve made of a singular membrane of tissue into a patient, the method may further comprise the step of removing at least a portion of a patient's atrioventricular valve by means of a cutting tool introduced through a percutaneous intercostal penetration and through an internal penetration on the cardiac wall. The method may further comprise fastening the atrioventricular valve within the left atrium by means of an instrument introduced through the percutaneous intercostal penetration and through the internal penetration. In one embodiment, the percutaneous intercostal penetration is created in a right lateral portion of a patient's chest.
A conventional procedure for approaching pulmonary veins in the left atrium is by intravascular catheterization from a femoral vein or artery through the cardiac septal which separates the right atrium and the left atrium. The disadvantages of an intravascular procedure include a long tortuous route (usually a catheter of longer than one meter) that is dangerous and tedious; limited catheter size (usually up to 6 or 7 French catheter size) that can't hold a folded atrioventricular valve; and a leaking cardiac septal that is difficult to re-seal. hi an alternate embodiment, a third inner medical device having a folded/retracted stentless and/or supportless atrioventricular valve of the present invention at its distal end is introduced through the proximal opening 88B. After the distal end reaches at about the atrioventricular annulus, the valve is deployed out ofthe distal end 96 ofthe inner medical device. Securing a heart valve onto the annulus location using a minimal invasive technique is well known to one who is skilled in the art and constitutes no part of the present invention.
The present invention discloses a method of forming a stentless and/or supportless atrioventricular valve intended for attaching to a circumferential valve ring and papillary muscles of a patient as afore-mentioned described. The method may comprise the steps of (a) selecting a singular membrane of biomaterial and an essentially flat sewing ring element, wherein said membrane comprises a hole in about a central region of said membrane and a periphery region, and wherein said sewing ring element comprises an outer diameter and an inner diameter defining an inner straight side portion, an outer straight side portion, a bottom side portion and a top side portion, said hole matching said inner diameter of said sewing ring element; (b) placing said sewing ring element on top of said membrane conformed to align said hole with the inner diameter of said ring element; (c) securing said membrane onto said sewing ring element at a contact region of said membrane to the bottom side portion of the ring element; (d) flapping the membrane around the outer straight side portion and the top side portion of said ring element; (e) inserting the periphery of said membrane through the inside diameter of the ring element configured to form a sewing ring with an inverted membrane around all ofthe bottom side portion, outer straight side portion, top side portion and inner straight side portion; and (f) trimming the membrane to form at least two cusps suitable for replacing in a diseased or dysfunctional atrioventricular valve of the patient.
Furthermore, the present invention discloses a method for minimally invasively delivering a stentless and/or supportless atrioventricular valve made of a singular membrane of tissue into a patient, said method comprising folding the valve within a lumen of delivery means for delivering through a cardiac wall into a left atrium of the patient. The method may comprise the steps of (a) advancing a delivery apparatus of the delivery means through a percutaneous intercostal penetration and reaching the cardiac wall, wherein said delivery apparatus comprises a cup balloon at a distal section of the delivery apparatus having a plurality of suction ports at a balloon rim of said cup balloon;
(b) deploying the cup balloon and applying suction to said plurality of suction ports to create an isolated enclosure around a distal region of the delivery apparatus; (c) introducing a sharp-end inner medical device inside said delivery apparatus toward the cardiac wall and creating a passthrough opemng on said wall; (d) withdrawing the sharp- end inner medical device from said delivery apparatus; (e) introducing a second imier medical device having the folded atrioventricular valve through the passthrough opening into the left atrium; and (f) delivering the atrioventricular valve suitable out of said second inner medical device for implanting at a heart valve location.
In operation, a delivery apparatus 80 of the present invention is deployed through an intercostal penetration. The delivery apparatus may be introduced through a cannula or trocar 104 positioned in one of percutaneous intercostal penetrations, the cannula or trocar having a proximal end disposed outside ofthe patient and a distal end disposed within the chest. In a minimally invasive procedure, a method for percutaneously delivering an atrioventricular valve for treating a leaky valve may comprise the steps of: (1) delivering the atrioventricular valve to the anatomical valvular position percutaneously during a delivery phase; (2) deploying the atrioventricular valve during a deployment phase; and (3) placing and securing the atrioventricular valve at about the anatomical valvular annulus. The method may further comprise forming a plurality of percutaneous intercostal penetrations in a patient's chest, each of the percutaneous intercostal penetrations being within an intercostal space between two adjacent ribs, wherein the atrioventricular valve is delivered through one ofthe percutaneous intercostal penetrations. hi addition to performing atrioventricular valve repair and replacement, the techniques of the invention also facilitate surgical intervention into other regions of the heart and great vessels. The delivery system and methods described above may be used to form an opening directly into the left ventricle, right atrium, or right ventricle, or into a great vessel such as the aorta, superior vena cava, inferior vena cava, pulmonary artery, or pulmonary vein, for surgical intervention in such cavities. For example, a penetration may be made in the wall of the aorta with a vacuumed enclosure, and the aortic valve may be repaired or replaced with a bioprosthesis, using techniques and delivery systems like those described above for atrioventricular valve replacement.
Moreover, the device systems and methods of the invention also facilitate intracardiac procedures such as repair of atrial or ventricular septal defects, electrophysiological mapping and ablation of the myocardium, electrophysiological mapping and ablation of the pulmonary veins, myocardial drilling, and other procedures. Furthemiore, delivery systems may be introduced through an opening into the heart or great vessel and advanced therefrom into vessels such as the coronary arteries to perform procedures such as angioplasty, atherectomy, coronary artery bypass grafting, or the pulmonary veins to perform procedures such as atrial fibrillation ablation.
An alternate aspect ofthe present invention is to provide a method of treating atrial fibrillation using a medical device with at least one radiofrequency electrode, the method comprising introducing the medical device through an intercostal penetration and an opening on a cardiac wall into a left atrium of a patient, wherein radiofrequency energy is provided through the at least one electrode to ablate at least one pulmonary vein in the left atrium. h one embodiment, a trocar may be placed at the intercostal penetration for the medical device to pass through. Further, the opening on the cardiac wall may be created by a delivery system having a delivery apparatus and a sharp-end inner medical device for creating said opening, the delivery apparatus comprising a cup balloon located at a distal section of said delivery apparatus configured for defining an isolated enclosure bordered by said cup balloon and said cardiac wall. Alternately, the delivery apparatus further comprises a plurality of suction ports located along a balloon rim of said cup balloon adapted for releasably securing said rim onto said cardiac wall.
From the foregoing description, it should now be appreciated that a stentless and/or supportless atrioventricular valve comprising a singular membrane of tissue with at least two cusps and methods of delivery in a minimally invasive manner have been disclosed. While the invention has been described with reference to a specific embodiment, the description is illustrative of the invention and is not to be construed as limiting the invention. Various modifications and applications may occur to those who are skilled in the art, without departing from the true spirit and scope of the invention, as described by the appended claims.

Claims

Claims:
1. A stentless atrioventricular valve comprising a singular membrane of tissue, said valve having a sewing ring comprising an opening defined by a perimeter including at least a first and a second straight side portions thereof, an anterior cusp hinged continuously from said first straight side portion, a posterior cusp hinged continuously from said second straight side portion opposite said anterior cusp, wherein said anterior cusp and said posterior cusp are an integral part of a continuum from said singular membrane configured to form a substantially tubular shape for use as the atrioventricular valve.
2. The stentless atrioventricular valve of claim 1, wherein the sewing ring is formed by an inverted flange portion of the combined cusps located at about the sewing ring that is configured to shape said sewing ring opening, wherein said flange portion from the cusps is an integral part of a continuum from said singular membrane.
3. The stentless atrioventricular valve of claim 1, wherein the anterior cusp and the posterior cusp further comprise texture elements at edge portions of the cusps configured to extend said texture elements for connection to papillary muscles in a ventricle cavity when the sewing ring is sutured to an atrioventricular junction of a patient heart.
4. The stentless atrioventricular valve of claim 1 further comprising a third cusp located between the anterior cusp and the posterior cusp, wherein the third cusp hinged continuously from a third straight side portion of the perimeter, said third cusp is an integral part of a continuum from said singular membrane configured to fomi a substantially tubular shape for use as the atrioventricular valve.
5. The stentless atrioventricular valve of claim 1, wherein the anterior cusp or the posterior cusp has a generally semicircular edge portion to enable it projecting deeply into said ventricle cavity.
6. The stentless atrioventricular valve of claim 1, the posterior cusp having a semicircular tip edge and two generally straight side edges that are joined at said semicircular tip edge, wherein each of said straight side edges is trimmed and configured at an angle of about less than 20 degrees from a reference central longitudinal line of said posterior cusp.
7. The stentless atrioventricular valve of claim 1, the anterior cusp having a semicircular tip edge and two generally straight side edges that are joined at said semicircular tip edge, wherein each of said straight side edges is trimmed and configured at an angle of about less than 20 degrees from a reference central longitudinal line of said anterior cusp.
8. The stentless atrioventricular valve of claim 1, wherein said sewing ring opening is D-shaped, and is matched by a correspondingly larger D-shaped external profile suitable for placing said atrioventricular valve in a patient heart.
9. The stentless atrioventricular valve of claim 1 or 4, wherein the sewing ring is formed by an inverted flange portion of the posterior and anterior cusps at about the sewing ring, the inverted flange portion being wrapped around and secured to a flat sewing ring element configured to shape said sewing ring opening, wherein said flange portion from the cusps is an integral part of a continuum from said singular membrane.
10. The stentless atrioventricular valve of claim 9, wherein the inverted flange portion is wrapped around and stitched to the flat sewing ring element.
11. The stentless atrioventricular valve of claim 9, wherein the sewing ring element is made of a biocompatible material selected from a group consisting of non- biodegradable plastic material, biodegradable plastic material, non-biodegradable biological material, or biodegradable biological material.
12. The stentless atrioventricular valve of claim 3, wherein the texture elements are made of polyester or polytetrafluoroethylene fabric.
13. The stentless atrioventricular valve of claim 3, wherein the texture elements are formed integral with the cusps and are provided with integral attachment portions at ends remote from the cusps for suturing to the papillary muscles.
14. The stentless atrioventricular valve of claim 1, wherein said membrane of tissue is chemically treated to reduce its antigenicity.
15. The stentless atrioventricular valve of claim 14, wherein said membrane of tissue is pericardium tissue selected from a group consisting of equine, bovine, porcine and ovine.
16. A method of forming a stentless atrioventricular valve intended for attaching to a circumferential valve ring and papillary muscles of a patient comprising: selecting a singular membrane of biomaterial and an essentially flat sewing ring element, wherein said membrane comprises a hole in about a central region of said membrane and a periphery region, and wherein said sewing ring element comprises an outer diameter and an inner diameter defining an inner straight side portion, an outer straight side portion, a bottom side portion and a top side portion, said hole matching said inner diameter of said sewing ring element; placing said sewing ring element on top of said membrane conformed to align said hole with the inner diameter of said ring element; securing said membrane onto said sewing ring element at a contact region of said membrane to the bottom side portion of the ring element; flapping the membrane around the outer straight side portion and the top side portion of said ring element; inserting the periphery of said membrane through the inside diameter of the ring element configured to form a sewing ring with an inverted membrane around all of the bottom side portion, outer straight side portion, top side portion and inner straight side portion; trimming the membrane to form at least two cusps suitable for replacing in a diseased or dysfunctional atrioventricular valve ofthe patient.
17. The method of forming a stentless atrioventricular valve of claim 16, wherein at least one of said at least two cusps has a semicircular tip edge and two generally straight side edges that are joined at said semicircular tip edge, wherein each of said straight side edges is trimmed and configured at an angle of about less than 20 degrees from a reference central longitudinal line of said cusp.
18. The method of forming a stentless atrioventricular valve of claim 16 further comprising a step of removing the ring element.
19. The method of forming a stentless atrioventricular valve of claim 16, wherein said membrane of biomaterial is tissue that is chemically treated to reduce its antigenicity.
20. The method of forming a stentless atrioventricular valve of claim 16, wherein said membrane of biomaterial is a synthetic polymer.
21. A method for minimally invasively delivering a supportless atrioventricular valve made of a singular membrane of tissue into a patient, said method comprising folding said valve within a lumen of delivery means for delivering said valve through a cardiac wall into a left atrium ofthe patient.
22. The method of claim 1, wherein said valve comprising a sewing ring having an opening defined by a perimeter including at least a first and a second straight side portions thereof, an anterior cusp hinged continuously from said first straight side portion, a posterior cusp hinged continuously from said second straight side portion opposite said anterior cusp, wherein said anterior cusp and said posterior cusp are an integral part of a continuum from said singular membrane configured to form a substantially tubular shape for use as the supportless atrioventricular valve.
23. The method of claim 2, wherein said singular membrane of tissue is chemically treated to reduce antigenicity of said membrane.
24. The method of claim 3, wherein said membrane of tissue is pericardium tissue selected from a group consisting of equine, bovine, porcine, and ovine.
25. The method of claim 1 further comprising steps of: (a) advancing a delivery apparatus of the delivery means through a percutaneous intercostal penetration and reaching the cardiac wall, wherein said delivery apparatus comprises a cup balloon at a distal section of the delivery apparatus having a plurality of suction ports at a balloon rim of said cup balloon; (b) deploying the cup balloon and applying suction to said plurality of suction ports to create an isolated enclosure around a distal region ofthe delivery apparatus; (c) introducing a sharp-end inner medical device inside said delivery apparatus toward the cardiac wall and creating a passthrough opening on said wall; (d) withdrawing the sharp-end inner medical device from said delivery apparatus; (e) introducing a second inner medical device having the folded supportless atrioventricular valve through the passthrough opening into the left atrium; and (f) delivering the atrioventricular valve suitable out of said second inner medical device for implanting at a heart valve location.
26. The method of claim 1 wherein the delivery means is introduced through a cannula positioned in a percutaneous intercostal penetration.
27. The method of claim 1 further comprising a step of removing at least a portion of a patient's atrioventricular valve by means of a cutting tool introduced through a percutaneous intercostal penetration and through an internal penetration on the cardiac wall.
28. The method of claim 7 further comprising fastening the supportless atrioventricular valve within the left atrium by means of an instrument introduced through the percutaneous intercostal penetration and through the internal penetration.
29. The method of claim 8 wherein the supportless atrioventricular valve is introduced through a cannula positioned in the percutaneous intercostal penetration.
30. The method of claim 7 wherein the percutaneous intercostal penetration is created in a right lateral portion of a patient's chest.
31. A delivery apparatus for accessing a left atrium of a patient through a cardiac wall, said delivery apparatus comprising a cup balloon located at a distal section of said delivery apparatus, wherein said cup balloon having a balloon rim configured for defining an isolated enclosure bordered by said balloon rim of said cup balloon and said cardiac wall.
32. The delivery apparatus of claim 11, wherein said delivery apparatus further comprises a plurality of suction ports located along the balloon rim of said cup balloon adapted for releasably securing said balloon rim onto said cardiac wall.
33. The delivery apparatus of claim 12, wherein a suction pressure of the plurality of suction ports is in the range of -5 to -100 mmHg.
34. The delivery apparatus of claim 12, wherein the cup balloon is made of a material selected from a group consisting of silicone, polyurethane, latex, and mixture thereof.
35. The delivery apparatus of claim 11, wherein a pressure for inflating said cup balloon is in the range of 10 to 100 mmHg.
36. The delivery apparatus of claim 11, wherein the delivery apparatus is made of a material selected from a group consisting of polyethylene, polypropylene, polycarbonate, nylon, polytetrafluoroethylene, polyurethane, stainless steel, Nitinol, titanium, polyimide, and polyester.
37. A method of treating atrial fibrillation using a medical device with at least one radiofrequency electrode, the method comprising introducing said medical device through an intercostal penetration and an opening on a cardiac wall into a left atrium of a patient, wherein radiofrequency energy is provided through said at least one electrode to ablate at least one pulmonary vein in the left atrium.
38. The method of claim 17, wherein a trocar is placed at the intercostal penetration for said medical device to pass through.
39. The method of claim 17, wherein the opening on the cardiac wall is created by a delivery system having a delivery apparatus and a shaφ-end inner medical device for creating said opening, the delivery apparatus comprising a cup balloon located at a distal section of said delivery apparatus configured for defining an isolated enclosure bordered by said cup balloon and said cardiac wall.
40. The method of claim 19, wherein said delivery apparatus further comprises a plurality of suction ports located along a balloon rim of said cup balloon adapted for releasably securing said rim onto said cardiac wall.
PCT/US2003/018375 2003-06-09 2003-06-09 Atrioventricular heart valve and minimally invasive delivery systems thereof WO2005004753A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US2003/018375 WO2005004753A1 (en) 2003-06-09 2003-06-09 Atrioventricular heart valve and minimally invasive delivery systems thereof
AU2003237985A AU2003237985A1 (en) 2003-06-09 2003-06-09 Atrioventricular heart valve and minimally invasive delivery systems thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/018375 WO2005004753A1 (en) 2003-06-09 2003-06-09 Atrioventricular heart valve and minimally invasive delivery systems thereof

Publications (1)

Publication Number Publication Date
WO2005004753A1 true WO2005004753A1 (en) 2005-01-20

Family

ID=34061412

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/018375 WO2005004753A1 (en) 2003-06-09 2003-06-09 Atrioventricular heart valve and minimally invasive delivery systems thereof

Country Status (2)

Country Link
AU (1) AU2003237985A1 (en)
WO (1) WO2005004753A1 (en)

Cited By (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462191B2 (en) 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
US7682390B2 (en) 2001-07-31 2010-03-23 Medtronic, Inc. Assembly for setting a valve prosthesis in a corporeal duct
US7758606B2 (en) 2000-06-30 2010-07-20 Medtronic, Inc. Intravascular filter with debris entrapment mechanism
US7780726B2 (en) 2001-07-04 2010-08-24 Medtronic, Inc. Assembly for placing a prosthetic valve in a duct in the body
US7871436B2 (en) 2007-02-16 2011-01-18 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US7972378B2 (en) 2008-01-24 2011-07-05 Medtronic, Inc. Stents for prosthetic heart valves
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8070801B2 (en) 2001-06-29 2011-12-06 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8142495B2 (en) 2006-05-15 2012-03-27 Edwards Lifesciences Ag System and a method for altering the geometry of the heart
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US8211169B2 (en) 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US8231670B2 (en) 2003-12-23 2012-07-31 Sadra Medical, Inc. Repositionable heart valve and method
US8246678B2 (en) 2003-12-23 2012-08-21 Sadra Medicl, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8252052B2 (en) 2003-12-23 2012-08-28 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8328868B2 (en) 2004-11-05 2012-12-11 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US8382826B2 (en) 2005-06-13 2013-02-26 Edwards Lifesciences Corporation Method of delivering a prosthetic heart valve
US8414641B2 (en) 2007-12-21 2013-04-09 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8460365B2 (en) 2005-09-21 2013-06-11 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8460373B2 (en) 2002-12-20 2013-06-11 Medtronic, Inc. Method for implanting a heart valve within an annulus of a patient
US8470023B2 (en) 2007-02-05 2013-06-25 Boston Scientific Scimed, Inc. Percutaneous valve, system, and method
US8506620B2 (en) 2005-09-26 2013-08-13 Medtronic, Inc. Prosthetic cardiac and venous valves
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US8529621B2 (en) 2001-05-17 2013-09-10 Edwards Lifesciences Corporation Methods of repairing an abnormal mitral valve
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8568473B2 (en) 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US8591570B2 (en) 2004-09-07 2013-11-26 Medtronic, Inc. Prosthetic heart valve for replacing previously implanted heart valve
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US8613765B2 (en) 2008-02-28 2013-12-24 Medtronic, Inc. Prosthetic heart valve systems
US8623076B2 (en) 2003-12-23 2014-01-07 Sadra Medical, Inc. Low profile heart valve and delivery system
US8628566B2 (en) 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US8668733B2 (en) 2004-06-16 2014-03-11 Sadra Medical, Inc. Everting heart valve
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US8721717B2 (en) 2003-12-19 2014-05-13 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
US8747459B2 (en) 2006-12-06 2014-06-10 Medtronic Corevalve Llc System and method for transapical delivery of an annulus anchored self-expanding valve
US8747463B2 (en) 2003-08-22 2014-06-10 Medtronic, Inc. Methods of using a prosthesis fixturing device
US8764821B2 (en) 2007-02-09 2014-07-01 Edwards Lifesciences Corporation Degenerative vavlular disease specific annuloplasty ring sets
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8784478B2 (en) 2006-10-16 2014-07-22 Medtronic Corevalve, Inc. Transapical delivery system with ventruculo-arterial overlfow bypass
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US8858620B2 (en) 2003-12-23 2014-10-14 Sadra Medical Inc. Methods and apparatus for endovascularly replacing a heart valve
US8858619B2 (en) 2002-04-23 2014-10-14 Medtronic, Inc. System and method for implanting a replacement valve
US8894703B2 (en) 2003-12-23 2014-11-25 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US8900295B2 (en) 2011-09-26 2014-12-02 Edwards Lifesciences Corporation Prosthetic valve with ventricular tethers
US8932349B2 (en) 2004-09-02 2015-01-13 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US8951280B2 (en) 2000-11-09 2015-02-10 Medtronic, Inc. Cardiac valve procedure methods and devices
US8956402B2 (en) 2001-06-29 2015-02-17 Medtronic, Inc. Apparatus for replacing a cardiac valve
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US8998976B2 (en) 2011-07-12 2015-04-07 Boston Scientific Scimed, Inc. Coupling system for medical devices
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US9011521B2 (en) 2003-12-23 2015-04-21 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9028542B2 (en) 2005-06-10 2015-05-12 Boston Scientific Scimed, Inc. Venous valve, system, and method
US9066799B2 (en) 1999-11-17 2015-06-30 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
US9125742B2 (en) 2005-12-15 2015-09-08 Georgia Tech Research Foundation Papillary muscle position control devices, systems, and methods
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US9237886B2 (en) 2007-04-20 2016-01-19 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9301843B2 (en) 2003-12-19 2016-04-05 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US9370419B2 (en) 2005-02-23 2016-06-21 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US9370421B2 (en) 2011-12-03 2016-06-21 Boston Scientific Scimed, Inc. Medical device handle
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US9415225B2 (en) 2005-04-25 2016-08-16 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US9474607B2 (en) 2010-11-30 2016-10-25 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US9498329B2 (en) 2004-11-19 2016-11-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9539092B2 (en) 2005-10-18 2017-01-10 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US9539088B2 (en) 2001-09-07 2017-01-10 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US9622859B2 (en) 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US9629718B2 (en) 2013-05-03 2017-04-25 Medtronic, Inc. Valve delivery tool
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US9775704B2 (en) 2004-04-23 2017-10-03 Medtronic3F Therapeutics, Inc. Implantable valve prosthesis
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US20170325938A1 (en) 2016-05-16 2017-11-16 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9861473B2 (en) 2005-04-15 2018-01-09 Boston Scientific Scimed Inc. Valve apparatus, system and method
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US9918833B2 (en) 2010-09-01 2018-03-20 Medtronic Vascular Galway Prosthetic valve support structure
US10039531B2 (en) 2005-12-15 2018-08-07 Georgia Tech Research Corporation Systems and methods to control the dimension of a heart valve
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US10201418B2 (en) 2010-09-10 2019-02-12 Symetis, SA Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10245142B2 (en) 2008-04-08 2019-04-02 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US10258465B2 (en) 2003-12-23 2019-04-16 Boston Scientific Scimed Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US10278805B2 (en) 2000-08-18 2019-05-07 Atritech, Inc. Expandable implant devices for filtering blood flow from atrial appendages
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10299922B2 (en) 2005-12-22 2019-05-28 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10335277B2 (en) 2015-07-02 2019-07-02 Boston Scientific Scimed Inc. Adjustable nosecone
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US10485976B2 (en) 1998-04-30 2019-11-26 Medtronic, Inc. Intracardiovascular access (ICVA™) system
US10555809B2 (en) 2012-06-19 2020-02-11 Boston Scientific Scimed, Inc. Replacement heart valve
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US10828154B2 (en) 2017-06-08 2020-11-10 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US10898325B2 (en) 2017-08-01 2021-01-26 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US10939996B2 (en) 2017-08-16 2021-03-09 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11191641B2 (en) 2018-01-19 2021-12-07 Boston Scientific Scimed, Inc. Inductance mode deployment sensors for transcatheter valve system
US11229517B2 (en) 2018-05-15 2022-01-25 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11241312B2 (en) 2018-12-10 2022-02-08 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
US11246625B2 (en) 2018-01-19 2022-02-15 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US11285002B2 (en) 2003-12-23 2022-03-29 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US11304802B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11771544B2 (en) 2011-05-05 2023-10-03 Symetis Sa Method and apparatus for compressing/loading stent-valves

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3739402A (en) * 1970-10-15 1973-06-19 Cutter Lab Bicuspid fascia lata valve
EP0276975A1 (en) * 1987-01-30 1988-08-03 Yoel Ovil Replacement of cardiac valves in heart surgery
US5156621A (en) * 1988-03-22 1992-10-20 Navia Jose A Stentless bioprosthetic cardiac valve
US5415667A (en) * 1990-06-07 1995-05-16 Frater; Robert W. M. Mitral heart valve replacements
US5554184A (en) * 1994-07-27 1996-09-10 Machiraju; Venkat R. Heart valve
US5824067A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Physiologic mitral valve bioprosthesis
US6358277B1 (en) * 2000-06-21 2002-03-19 The International Heart Institute Of Montana Foundation Atrio-ventricular valvular device
WO2003037227A2 (en) * 2001-10-29 2003-05-08 The University Court Of The University Of Glasgow Mitral valve prosthesis

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3739402A (en) * 1970-10-15 1973-06-19 Cutter Lab Bicuspid fascia lata valve
EP0276975A1 (en) * 1987-01-30 1988-08-03 Yoel Ovil Replacement of cardiac valves in heart surgery
US5156621A (en) * 1988-03-22 1992-10-20 Navia Jose A Stentless bioprosthetic cardiac valve
US5415667A (en) * 1990-06-07 1995-05-16 Frater; Robert W. M. Mitral heart valve replacements
US5554184A (en) * 1994-07-27 1996-09-10 Machiraju; Venkat R. Heart valve
US5824067A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Physiologic mitral valve bioprosthesis
US6358277B1 (en) * 2000-06-21 2002-03-19 The International Heart Institute Of Montana Foundation Atrio-ventricular valvular device
WO2003037227A2 (en) * 2001-10-29 2003-05-08 The University Court Of The University Of Glasgow Mitral valve prosthesis

Cited By (328)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10485976B2 (en) 1998-04-30 2019-11-26 Medtronic, Inc. Intracardiovascular access (ICVA™) system
US10219901B2 (en) 1999-11-17 2019-03-05 Medtronic CV Luxembourg S.a.r.l. Prosthetic valve for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8721708B2 (en) 1999-11-17 2014-05-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8998979B2 (en) 1999-11-17 2015-04-07 Medtronic Corevalve Llc Transcatheter heart valves
US9060856B2 (en) 1999-11-17 2015-06-23 Medtronic Corevalve Llc Transcatheter heart valves
US8986329B2 (en) 1999-11-17 2015-03-24 Medtronic Corevalve Llc Methods for transluminal delivery of prosthetic valves
US8876896B2 (en) 1999-11-17 2014-11-04 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US9066799B2 (en) 1999-11-17 2015-06-30 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US9962258B2 (en) 1999-11-17 2018-05-08 Medtronic CV Luxembourg S.a.r.l. Transcatheter heart valves
US8777980B2 (en) 2000-06-30 2014-07-15 Medtronic, Inc. Intravascular filter with debris entrapment mechanism
US8092487B2 (en) 2000-06-30 2012-01-10 Medtronic, Inc. Intravascular filter with debris entrapment mechanism
US7758606B2 (en) 2000-06-30 2010-07-20 Medtronic, Inc. Intravascular filter with debris entrapment mechanism
US10278805B2 (en) 2000-08-18 2019-05-07 Atritech, Inc. Expandable implant devices for filtering blood flow from atrial appendages
US8951280B2 (en) 2000-11-09 2015-02-10 Medtronic, Inc. Cardiac valve procedure methods and devices
US8529621B2 (en) 2001-05-17 2013-09-10 Edwards Lifesciences Corporation Methods of repairing an abnormal mitral valve
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US8956402B2 (en) 2001-06-29 2015-02-17 Medtronic, Inc. Apparatus for replacing a cardiac valve
US8070801B2 (en) 2001-06-29 2011-12-06 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8002826B2 (en) 2001-07-04 2011-08-23 Medtronic Corevalve Llc Assembly for placing a prosthetic valve in a duct in the body
US8628570B2 (en) 2001-07-04 2014-01-14 Medtronic Corevalve Llc Assembly for placing a prosthetic valve in a duct in the body
US9149357B2 (en) 2001-07-04 2015-10-06 Medtronic CV Luxembourg S.a.r.l. Heart valve assemblies
US7780726B2 (en) 2001-07-04 2010-08-24 Medtronic, Inc. Assembly for placing a prosthetic valve in a duct in the body
US7682390B2 (en) 2001-07-31 2010-03-23 Medtronic, Inc. Assembly for setting a valve prosthesis in a corporeal duct
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US10188518B2 (en) 2001-08-28 2019-01-29 Edwards Lifesciences Corporation Annuloplasty ring with variable cross-section
US9414922B2 (en) 2001-08-28 2016-08-16 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US9539088B2 (en) 2001-09-07 2017-01-10 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US10342657B2 (en) 2001-09-07 2019-07-09 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US8858619B2 (en) 2002-04-23 2014-10-14 Medtronic, Inc. System and method for implanting a replacement valve
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US9333078B2 (en) 2002-12-20 2016-05-10 Medtronic, Inc. Heart valve assemblies
US8460373B2 (en) 2002-12-20 2013-06-11 Medtronic, Inc. Method for implanting a heart valve within an annulus of a patient
US8747463B2 (en) 2003-08-22 2014-06-10 Medtronic, Inc. Methods of using a prosthesis fixturing device
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US10869764B2 (en) 2003-12-19 2020-12-22 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8721717B2 (en) 2003-12-19 2014-05-13 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US9301843B2 (en) 2003-12-19 2016-04-05 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US9358106B2 (en) 2003-12-23 2016-06-07 Boston Scientific Scimed Inc. Methods and apparatus for performing valvuloplasty
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9277991B2 (en) 2003-12-23 2016-03-08 Boston Scientific Scimed, Inc. Low profile heart valve and delivery system
US11696825B2 (en) 2003-12-23 2023-07-11 Boston Scientific Scimed, Inc. Replacement valve and anchor
US9393113B2 (en) 2003-12-23 2016-07-19 Boston Scientific Scimed Inc. Retrievable heart valve anchor and method
US9585749B2 (en) 2003-12-23 2017-03-07 Boston Scientific Scimed, Inc. Replacement heart valve assembly
US9861476B2 (en) 2003-12-23 2018-01-09 Boston Scientific Scimed Inc. Leaflet engagement elements and methods for use thereof
US9872768B2 (en) 2003-12-23 2018-01-23 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US9011521B2 (en) 2003-12-23 2015-04-21 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US9358110B2 (en) 2003-12-23 2016-06-07 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US9956075B2 (en) 2003-12-23 2018-05-01 Boston Scientific Scimed Inc. Methods and apparatus for endovascularly replacing a heart valve
US11285002B2 (en) 2003-12-23 2022-03-29 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8623076B2 (en) 2003-12-23 2014-01-07 Sadra Medical, Inc. Low profile heart valve and delivery system
US8623078B2 (en) 2003-12-23 2014-01-07 Sadra Medical, Inc. Replacement valve and anchor
US10478289B2 (en) 2003-12-23 2019-11-19 Boston Scientific Scimed, Inc. Replacement valve and anchor
US9308085B2 (en) 2003-12-23 2016-04-12 Boston Scientific Scimed, Inc. Repositionable heart valve and method
US10426608B2 (en) 2003-12-23 2019-10-01 Boston Scientific Scimed, Inc. Repositionable heart valve
US8894703B2 (en) 2003-12-23 2014-11-25 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US10413412B2 (en) 2003-12-23 2019-09-17 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US9585750B2 (en) 2003-12-23 2017-03-07 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US10413409B2 (en) 2003-12-23 2019-09-17 Boston Scientific Scimed, Inc. Systems and methods for delivering a medical implant
US10357359B2 (en) 2003-12-23 2019-07-23 Boston Scientific Scimed Inc Methods and apparatus for endovascularly replacing a patient's heart valve
US9320599B2 (en) 2003-12-23 2016-04-26 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US10716663B2 (en) 2003-12-23 2020-07-21 Boston Scientific Scimed, Inc. Methods and apparatus for performing valvuloplasty
US10925724B2 (en) 2003-12-23 2021-02-23 Boston Scientific Scimed, Inc. Replacement valve and anchor
US10335273B2 (en) 2003-12-23 2019-07-02 Boston Scientific Scimed Inc. Leaflet engagement elements and methods for use thereof
US10314695B2 (en) 2003-12-23 2019-06-11 Boston Scientific Scimed Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US9532872B2 (en) 2003-12-23 2017-01-03 Boston Scientific Scimed, Inc. Systems and methods for delivering a medical implant
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US11185408B2 (en) 2003-12-23 2021-11-30 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US10258465B2 (en) 2003-12-23 2019-04-16 Boston Scientific Scimed Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8252052B2 (en) 2003-12-23 2012-08-28 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8246678B2 (en) 2003-12-23 2012-08-21 Sadra Medicl, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US10206774B2 (en) 2003-12-23 2019-02-19 Boston Scientific Scimed Inc. Low profile heart valve and delivery system
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8858620B2 (en) 2003-12-23 2014-10-14 Sadra Medical Inc. Methods and apparatus for endovascularly replacing a heart valve
US8231670B2 (en) 2003-12-23 2012-07-31 Sadra Medical, Inc. Repositionable heart valve and method
US8840662B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve and method
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US8535373B2 (en) 2004-03-03 2013-09-17 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US9867695B2 (en) 2004-03-03 2018-01-16 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US9775704B2 (en) 2004-04-23 2017-10-03 Medtronic3F Therapeutics, Inc. Implantable valve prosthesis
US9744035B2 (en) 2004-06-16 2017-08-29 Boston Scientific Scimed, Inc. Everting heart valve
US11484405B2 (en) 2004-06-16 2022-11-01 Boston Scientific Scimed, Inc. Everting heart valve
US8668733B2 (en) 2004-06-16 2014-03-11 Sadra Medical, Inc. Everting heart valve
US8992608B2 (en) 2004-06-16 2015-03-31 Sadra Medical, Inc. Everting heart valve
US7462191B2 (en) 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
US8932349B2 (en) 2004-09-02 2015-01-13 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US9918834B2 (en) 2004-09-02 2018-03-20 Boston Scientific Scimed, Inc. Cardiac valve, system and method
US8591570B2 (en) 2004-09-07 2013-11-26 Medtronic, Inc. Prosthetic heart valve for replacing previously implanted heart valve
US9480556B2 (en) 2004-09-07 2016-11-01 Medtronic, Inc. Replacement prosthetic heart valve, system and method of implant
US11253355B2 (en) 2004-09-07 2022-02-22 Medtronic, Inc. Replacement prosthetic heart valve, system and method of implant
US8617236B2 (en) 2004-11-05 2013-12-31 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US10531952B2 (en) 2004-11-05 2020-01-14 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US8328868B2 (en) 2004-11-05 2012-12-11 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US9498329B2 (en) 2004-11-19 2016-11-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US9622859B2 (en) 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8920492B2 (en) 2005-02-10 2014-12-30 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9895223B2 (en) 2005-02-10 2018-02-20 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8539662B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac-valve prosthesis
US9486313B2 (en) 2005-02-10 2016-11-08 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9808341B2 (en) 2005-02-23 2017-11-07 Boston Scientific Scimed Inc. Valve apparatus, system and method
US9370419B2 (en) 2005-02-23 2016-06-21 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US8500802B2 (en) 2005-04-08 2013-08-06 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US9861473B2 (en) 2005-04-15 2018-01-09 Boston Scientific Scimed Inc. Valve apparatus, system and method
US10549101B2 (en) 2005-04-25 2020-02-04 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US9415225B2 (en) 2005-04-25 2016-08-16 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US9649495B2 (en) 2005-04-25 2017-05-16 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
USD812226S1 (en) 2005-05-13 2018-03-06 Medtronic Corevalve Llc Heart valve prosthesis
US11284997B2 (en) 2005-05-13 2022-03-29 Medtronic CV Luxembourg S.a.r.l Heart valve prosthesis and methods of manufacture and use
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US9060857B2 (en) 2005-05-13 2015-06-23 Medtronic Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US9504564B2 (en) 2005-05-13 2016-11-29 Medtronic Corevalve Llc Heart valve prosthesis and methods of manufacture and use
USD732666S1 (en) 2005-05-13 2015-06-23 Medtronic Corevalve, Inc. Heart valve prosthesis
US10478291B2 (en) 2005-05-13 2019-11-19 Medtronic CV Luxembourg S.a.r.l Heart valve prosthesis and methods of manufacture and use
US8211169B2 (en) 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US9028542B2 (en) 2005-06-10 2015-05-12 Boston Scientific Scimed, Inc. Venous valve, system, and method
US11337812B2 (en) 2005-06-10 2022-05-24 Boston Scientific Scimed, Inc. Venous valve, system and method
US8382826B2 (en) 2005-06-13 2013-02-26 Edwards Lifesciences Corporation Method of delivering a prosthetic heart valve
US8460365B2 (en) 2005-09-21 2013-06-11 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8672997B2 (en) 2005-09-21 2014-03-18 Boston Scientific Scimed, Inc. Valve with sinus
US9474609B2 (en) 2005-09-21 2016-10-25 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US10548734B2 (en) 2005-09-21 2020-02-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8506620B2 (en) 2005-09-26 2013-08-13 Medtronic, Inc. Prosthetic cardiac and venous valves
US10624739B2 (en) 2005-10-18 2020-04-21 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US9839514B2 (en) 2005-10-18 2017-12-12 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US9539092B2 (en) 2005-10-18 2017-01-10 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US10039531B2 (en) 2005-12-15 2018-08-07 Georgia Tech Research Corporation Systems and methods to control the dimension of a heart valve
US9125742B2 (en) 2005-12-15 2015-09-08 Georgia Tech Research Foundation Papillary muscle position control devices, systems, and methods
US10010419B2 (en) 2005-12-15 2018-07-03 Georgia Tech Research Corporation Papillary muscle position control devices, systems, and methods
US8568473B2 (en) 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US10314701B2 (en) 2005-12-22 2019-06-11 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10299922B2 (en) 2005-12-22 2019-05-28 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US9331328B2 (en) 2006-03-28 2016-05-03 Medtronic, Inc. Prosthetic cardiac valve from pericardium material and methods of making same
US10058421B2 (en) 2006-03-28 2018-08-28 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US8591576B2 (en) 2006-05-15 2013-11-26 Edwards Lifesciences Ag Method for altering the geometry of the heart
US8142495B2 (en) 2006-05-15 2012-03-27 Edwards Lifesciences Ag System and a method for altering the geometry of the heart
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US10004601B2 (en) 2006-09-19 2018-06-26 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US8747460B2 (en) 2006-09-19 2014-06-10 Medtronic Ventor Technologies Ltd. Methods for implanting a valve prothesis
US9827097B2 (en) 2006-09-19 2017-11-28 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US10543077B2 (en) 2006-09-19 2020-01-28 Medtronic, Inc. Sinus-engaging valve fixation member
US9387071B2 (en) 2006-09-19 2016-07-12 Medtronic, Inc. Sinus-engaging valve fixation member
US8771345B2 (en) 2006-09-19 2014-07-08 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US8414643B2 (en) 2006-09-19 2013-04-09 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8771346B2 (en) 2006-09-19 2014-07-08 Medtronic Ventor Technologies Ltd. Valve prosthetic fixation techniques using sandwiching
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8348995B2 (en) 2006-09-19 2013-01-08 Medtronic Ventor Technologies, Ltd. Axial-force fixation member for valve
US9301834B2 (en) 2006-09-19 2016-04-05 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US10195033B2 (en) 2006-09-19 2019-02-05 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US11304802B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8348996B2 (en) 2006-09-19 2013-01-08 Medtronic Ventor Technologies Ltd. Valve prosthesis implantation techniques
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
US8876894B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Leaflet-sensitive valve fixation member
US8876895B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Valve fixation member having engagement arms
US9642704B2 (en) 2006-09-19 2017-05-09 Medtronic Ventor Technologies Ltd. Catheter for implanting a valve prosthesis
US11304801B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US9913714B2 (en) 2006-09-19 2018-03-13 Medtronic, Inc. Sinus-engaging valve fixation member
US9138312B2 (en) 2006-09-19 2015-09-22 Medtronic Ventor Technologies Ltd. Valve prostheses
US8784478B2 (en) 2006-10-16 2014-07-22 Medtronic Corevalve, Inc. Transapical delivery system with ventruculo-arterial overlfow bypass
US9295550B2 (en) 2006-12-06 2016-03-29 Medtronic CV Luxembourg S.a.r.l. Methods for delivering a self-expanding valve
US8747459B2 (en) 2006-12-06 2014-06-10 Medtronic Corevalve Llc System and method for transapical delivery of an annulus anchored self-expanding valve
US8348999B2 (en) 2007-01-08 2013-01-08 California Institute Of Technology In-situ formation of a valve
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US11504239B2 (en) 2007-02-05 2022-11-22 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US10226344B2 (en) 2007-02-05 2019-03-12 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US9421083B2 (en) 2007-02-05 2016-08-23 Boston Scientific Scimed Inc. Percutaneous valve, system and method
US8470023B2 (en) 2007-02-05 2013-06-25 Boston Scientific Scimed, Inc. Percutaneous valve, system, and method
US8764821B2 (en) 2007-02-09 2014-07-01 Edwards Lifesciences Corporation Degenerative vavlular disease specific annuloplasty ring sets
US9011529B2 (en) 2007-02-09 2015-04-21 Edwards Lifesciences Corporation Mitral annuloplasty rings with sewing cuff
US9504568B2 (en) 2007-02-16 2016-11-29 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US7871436B2 (en) 2007-02-16 2011-01-18 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9237886B2 (en) 2007-04-20 2016-01-19 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US9585754B2 (en) 2007-04-20 2017-03-07 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US10842629B2 (en) 2007-09-07 2020-11-24 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US11576784B2 (en) 2007-09-07 2023-02-14 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US10966823B2 (en) 2007-10-12 2021-04-06 Sorin Group Italia S.R.L. Expandable valve prosthesis with sealing mechanism
US8414641B2 (en) 2007-12-21 2013-04-09 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US9333100B2 (en) 2008-01-24 2016-05-10 Medtronic, Inc. Stents for prosthetic heart valves
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US11083573B2 (en) 2008-01-24 2021-08-10 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US8685077B2 (en) 2008-01-24 2014-04-01 Medtronics, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US10016274B2 (en) 2008-01-24 2018-07-10 Medtronic, Inc. Stent for prosthetic heart valves
US8673000B2 (en) 2008-01-24 2014-03-18 Medtronic, Inc. Stents for prosthetic heart valves
US8628566B2 (en) 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
US11284999B2 (en) 2008-01-24 2022-03-29 Medtronic, Inc. Stents for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US11786367B2 (en) 2008-01-24 2023-10-17 Medtronic, Inc. Stents for prosthetic heart valves
US9925079B2 (en) 2008-01-24 2018-03-27 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US9339382B2 (en) 2008-01-24 2016-05-17 Medtronic, Inc. Stents for prosthetic heart valves
US8157852B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US10820993B2 (en) 2008-01-24 2020-11-03 Medtronic, Inc. Stents for prosthetic heart valves
US10758343B2 (en) 2008-01-24 2020-09-01 Medtronic, Inc. Stent for prosthetic heart valves
US11259919B2 (en) 2008-01-24 2022-03-01 Medtronic, Inc. Stents for prosthetic heart valves
US11607311B2 (en) 2008-01-24 2023-03-21 Medtronic, Inc. Stents for prosthetic heart valves
US10646335B2 (en) 2008-01-24 2020-05-12 Medtronic, Inc. Stents for prosthetic heart valves
US10639182B2 (en) 2008-01-24 2020-05-05 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US7972378B2 (en) 2008-01-24 2011-07-05 Medtronic, Inc. Stents for prosthetic heart valves
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8961593B2 (en) 2008-02-28 2015-02-24 Medtronic, Inc. Prosthetic heart valve systems
US8613765B2 (en) 2008-02-28 2013-12-24 Medtronic, Inc. Prosthetic heart valve systems
US10856979B2 (en) 2008-03-18 2020-12-08 Medtronic Ventor Technologies Ltd. Valve suturing and implantation procedures
US11602430B2 (en) 2008-03-18 2023-03-14 Medtronic Ventor Technologies Ltd. Valve suturing and implantation procedures
US9592120B2 (en) 2008-03-18 2017-03-14 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US11278408B2 (en) 2008-03-18 2022-03-22 Medtronic Venter Technologies, Ltd. Valve suturing and implantation procedures
US10245142B2 (en) 2008-04-08 2019-04-02 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US8511244B2 (en) 2008-04-23 2013-08-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US9943407B2 (en) 2008-09-15 2018-04-17 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US10806570B2 (en) 2008-09-15 2020-10-20 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US11026786B2 (en) 2008-09-15 2021-06-08 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
US11166815B2 (en) 2008-09-17 2021-11-09 Medtronic CV Luxembourg S.a.r.l Delivery system for deployment of medical devices
US9532873B2 (en) 2008-09-17 2017-01-03 Medtronic CV Luxembourg S.a.r.l. Methods for deployment of medical devices
US10321997B2 (en) 2008-09-17 2019-06-18 Medtronic CV Luxembourg S.a.r.l. Delivery system for deployment of medical devices
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US10098733B2 (en) 2008-12-23 2018-10-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
US10548730B2 (en) 2010-02-03 2020-02-04 Edwards Lifesciences Corporation Devices for remodeling a valve annulus and ventricle
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US11833041B2 (en) 2010-04-01 2023-12-05 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US11554010B2 (en) 2010-04-01 2023-01-17 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US10716665B2 (en) 2010-04-01 2020-07-21 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US9925044B2 (en) 2010-04-01 2018-03-27 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US10940003B2 (en) 2010-08-24 2021-03-09 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US10182912B2 (en) 2010-08-24 2019-01-22 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US9918833B2 (en) 2010-09-01 2018-03-20 Medtronic Vascular Galway Prosthetic valve support structure
US11786368B2 (en) 2010-09-01 2023-10-17 Medtronic Vascular Galway Prosthetic valve support structure
US10835376B2 (en) 2010-09-01 2020-11-17 Medtronic Vascular Galway Prosthetic valve support structure
US10201418B2 (en) 2010-09-10 2019-02-12 Symetis, SA Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US10869760B2 (en) 2010-09-10 2020-12-22 Symetis Sa Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US9474607B2 (en) 2010-11-30 2016-10-25 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US11872132B2 (en) 2010-11-30 2024-01-16 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US10543089B2 (en) 2010-11-30 2020-01-28 Edwards Lifesciences Corporation Annuloplasty ring with reduced dehiscence
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US11771544B2 (en) 2011-05-05 2023-10-03 Symetis Sa Method and apparatus for compressing/loading stent-valves
US8998976B2 (en) 2011-07-12 2015-04-07 Boston Scientific Scimed, Inc. Coupling system for medical devices
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
USRE47490E1 (en) 2011-09-26 2019-07-09 Edwards Lifesciences Corporation Prosthetic valve with ventricular tethers
US8900295B2 (en) 2011-09-26 2014-12-02 Edwards Lifesciences Corporation Prosthetic valve with ventricular tethers
US9370421B2 (en) 2011-12-03 2016-06-21 Boston Scientific Scimed, Inc. Medical device handle
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US9138314B2 (en) 2011-12-29 2015-09-22 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US11382739B2 (en) 2012-06-19 2022-07-12 Boston Scientific Scimed, Inc. Replacement heart valve
US10555809B2 (en) 2012-06-19 2020-02-11 Boston Scientific Scimed, Inc. Replacement heart valve
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US11045319B2 (en) 2013-03-14 2021-06-29 Edwards Lifesciences Corporation Methods of forming heat set annuloplasty rings
US10265171B2 (en) 2013-03-14 2019-04-23 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US10568739B2 (en) 2013-05-03 2020-02-25 Medtronic, Inc. Valve delivery tool
US11793637B2 (en) 2013-05-03 2023-10-24 Medtronic, Inc. Valve delivery tool
US9629718B2 (en) 2013-05-03 2017-04-25 Medtronic, Inc. Valve delivery tool
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US11065113B2 (en) 2015-03-13 2021-07-20 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11471280B2 (en) 2015-06-09 2022-10-18 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11324593B2 (en) 2015-06-09 2022-05-10 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10335277B2 (en) 2015-07-02 2019-07-02 Boston Scientific Scimed Inc. Adjustable nosecone
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US11730595B2 (en) 2015-07-02 2023-08-22 Boston Scientific Scimed, Inc. Adjustable nosecone
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10856973B2 (en) 2015-08-12 2020-12-08 Boston Scientific Scimed, Inc. Replacement heart valve implant
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US11382742B2 (en) 2016-05-13 2022-07-12 Boston Scientific Scimed, Inc. Medical device handle
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US10709552B2 (en) 2016-05-16 2020-07-14 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US20170325938A1 (en) 2016-05-16 2017-11-16 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US10828154B2 (en) 2017-06-08 2020-11-10 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US10898325B2 (en) 2017-08-01 2021-01-26 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US10939996B2 (en) 2017-08-16 2021-03-09 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11191641B2 (en) 2018-01-19 2021-12-07 Boston Scientific Scimed, Inc. Inductance mode deployment sensors for transcatheter valve system
US11246625B2 (en) 2018-01-19 2022-02-15 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11229517B2 (en) 2018-05-15 2022-01-25 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
US11241312B2 (en) 2018-12-10 2022-02-08 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading

Also Published As

Publication number Publication date
AU2003237985A1 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
US6974464B2 (en) Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US7041132B2 (en) Percutaneously delivered heart valve and delivery means thereof
WO2005004753A1 (en) Atrioventricular heart valve and minimally invasive delivery systems thereof
US10842623B2 (en) Methods of implanting prosthetic heart valve using position markers
US10702383B2 (en) Methods of delivering and implanting resilient prosthetic surgical heart valves
US6830586B2 (en) Stentless atrioventricular heart valve fabricated from a singular flat membrane
US6830585B1 (en) Percutaneously deliverable heart valve and methods of implantation
US10932904B2 (en) Artificial heart valve
US6875231B2 (en) Percutaneously deliverable heart valve
US11395734B2 (en) Prosthetic valve and prosthetic valve implanting method
US9629720B2 (en) Apparatus and methods for treating cardiac valve regurgitation
AU2002362442B2 (en) Methods and devices for heart valve treatments
JP6144009B2 (en) Stent for positioning and securing a valve prosthesis at a patient's heart implantation site
JP2017109140A (en) Stent for positioning and anchoring of valvular prosthesis in implantation site in heart of patient
AU2002362442A1 (en) Methods and devices for heart valve treatments
JP2010188140A (en) Implantable prosthetic valve

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP